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Abstract(
In recent decades, gold nanoparticles (AuNPs) have been pushed to the forefront of 
nanomaterial research because of their unique size-dependent physical, chemical and 
biological properties. As a result, proper surface functionalization would enable control over 
these desirable properties for potential applications in biomedicine, electronics or catalysis. 
Over the past few years, the Workentin research group has developed a toolbox of sophisticated 
methods for the functionalization of small (1-5 nm) AuNP systems by designing functional 
AuNP templates. These templates are easy to synthesize and can be used to effectively 
incorporate functionality on the AuNP surface using click and bioorthogonal interfacial 
chemistry. In this thesis the development of a novel ortho-naphthoquinone methide (oNQM) 
modified AuNP template is described that will allow for unprecedented photochemical spatial 
and temporal control of reactivity. The first steps towards the development of an innovative 
large AuNP (> 10 nm) template are also presented to expand the scope of interfacial 
functionalization and exploit their interesting optical properties.  
 
Keywords: Surface modification, gold nanoparticles, photochemistry, click chemistry, 
bioorthogonal chemistry. 
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CHAPTER(1(
(
1.1#Introduction#
Surface modification techniques allow for the introduction of novel physical, chemical 
or biological properties to a material. For potential applications, proper surface 
functionalization is a perquisite to enable control of the surface interactions with the 
environment as well as other moieties or molecules. By placing appropriate functional 
molecules on the surface of a material, the resulting surface interactions play a vital role in 
directly affecting the stability and subsequent function of the material. As a result, the 
exploitation of these surface engineered materials has led to great advances in technology and 
biomedicine. For example, in recent years’ quantum dot (QD) televisions have emerged as 
next generation technology as a result of the unique size-dependent optical properties of the 
inorganic nanoparticles. Through research into surface modification techniques to make QDs 
water soluble and targetable to specific biomolecules, QDs have also demonstrated promising 
applications as in vitro and in vivo imaging agents.[1] But despite the recent popularity of QDs, 
perhaps the most studied nanomaterial in literature are gold nanoparticles (AuNPs) owing to 
their unique and tunable properties. In general, the ability to modify the surface of a material 
allows for diverse functionalization for use in a wide range of applications. As a result, AuNPs 
have been used in numerous applications including electronics,[2] catalysis,[3] chemical and 
biological sensing[4] and drug delivery.[5]  
 
1.2#Properties#of#AuNPs#
AuNPs are commonly defined as a stable colloidal suspension of gold atom clusters 
ranging in diameter from 1 to 150 nm with properties differing between bulk gold and gold 
atoms. As described in Figure 1.1, AuNPs normally range in size over a narrow size 
distribution whereas Au nanoclusters are atomically precise AuNPs. Despite their use for 
staining glass in Roman times, the chemistry of AuNPs was not investigated until the 1850s 
by the work of Michael Faraday who observed the difference in optical properties and light 
scattering ability between colloidal gold solutions and bulk gold.[6] He prepared colloidal gold 
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by reducing an aqueous solution of a gold salt with a solution of phosphorus in carbon 
disulfide. Interestingly, transmission electron microscopy (TEM) images of Faraday’s AuNPs 
later revealed that he had synthesized AuNPs with an average size of 6 ± 2 nm.[7]  
 
Figure 1.1: A representation of the reduction of a metal from the large bulk material to smaller 
nanoparticles of varying size to the individual atoms that make up the material.  
AuNPs come in many different sizes (1-150 nm) but also many different shapes such 
as nanospheres, nanorods and nanostars (Figure 1.2). In this thesis, I present work with 
solutions of gold nanospheres and will refer to them as AuNPs. As described in Figure 1.3, 
AuNPs are composed of a metal core and usually capped by an organic layer, also known as 
the ligand corona, which protects the naked AuNPs from aggregation. Among all 
nanomaterials, AuNPs are often regarded as the most promising template for biomedical 
applications because of unique physical and chemical properties. AuNPs feature: (i) high 
chemical stability (ii) high surface area-to-volume ratio (iii) low toxicity (iv) size and shape 
dependent optical properties. As a result of these properties, AuNPs have been investigated 
for biomedical applications in medical diagnostics and therapeutics such as drug delivery 
systems[8] as well as imaging agents for magnetic resonance imaging (MRI)[9] and computed 
tomography (CT).[10]  
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Figure 1.2: TEM images of gold (A) nanospheres (B) nanorods (C) nanostars. The scale bar 
is indicated. Reprinted with permission from reference 11.[11] 
In terms of chemical stability, AuNPs do not oxidize under ambient conditions similar 
to bulk gold. As a result, AuNPs are easy to work with in a laboratory setting and are regarded 
as one of the most stable metal nanoparticle. However, what makes gold really special are the 
remarkable surface properties of the nanoparticles.[12] As a result of the high surface-area-to-
volume ratio, at the nanoscale, a large fraction of the gold atoms are concentrated at the 
surface. Interestingly, these surface atoms seem to exhibit incomplete valence in the sense that 
they are only bound to the internal atoms and the external sites remain available for interacting 
with donor-acceptor species, or ligands. Thus, the application of hard and soft acid-base theory 
(HSAB) can be helpful in understanding the coordination chemistry of AuNPs.[13] In HSAB 
theory, the Au core is considered a soft acid and therefore would prefer to bind soft bases that 
contain larger and more polarizable donor atoms. As a result, the surface of AuNPs may be 
derivatized with thiols[14] (sulfur, S), phosphines[15] (phosphorus, P) as well as amines[16] 
(nitrogen, N). However, sulfur is more commonly used as the donor atom for decorating Au 
surfaces as the resulting gold-sulfur bond is similar in strength to that of a covalent bond.[17] 
This interaction is usually mediated through the sulfhydryl (SH) functional group in thiols 
(RSH). It is also widely accepted that the covalent interaction at the gold-sulfur interface 
requires the formation of a gold-thiolate (S–) bond. This covalent bond in turn gives rise to a 
very robust, but more importantly, modifiable interaction that provides stabilization and 
functionalization to the system so that it can be used in a wide range of applications. As a 
result of the high surface-area-to-volume ratio, it is therefore possible to modify the Au surface 
to a very large extent which can drastically alter the chemical and physical properties 
producing a novel functional material. There are three main strategies used for the preparation 
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of functionalized AuNPs that will be discussed in detail later: (i) direct synthesis (ii) place (or 
ligand) exchange reactions (iii) post-synthetic interfacial reactions. Therefore, functionality 
can be installed to AuNPs when they are modified with ligands that contain small molecules, 
polymers, or biomolecules. These appropriately functionalized AuNPs can then be used in 
biomedical applications.  
 
Figure 1.3: Cartoon representation of a stabilized AuNP depicting the gold core (Au0), surface 
(AuI) and ligand corona.  
However, in order for AuNPs to be useful in biomedical applications, it is paramount 
that they do not inhibit or disrupt normal biological processes. Thankfully, AuNPs display 
great biocompatibility and have emerged as powerful multifunctional agents for anti-cancer 
treatments. A recent in vitro study showed the cytotoxicity profile of NPs based on their 
surface chemistry, morphology and size.[11] The authors investigated nanospheres, nanorods 
and nanostars of different sizes and concluded that the morphology and size of the 
nanoparticles only slightly affected cell viability. The surface chemistry had the most 
predominant effects on cytotoxicity depending on the type of ligand and functional groups 
present. It is important to note that PEG modified nanoparticles were determined to be the 
least toxic of the three ligands studied. Another study by Pan et al. revealed that AuNPs in the 
1-2 nm range exhibited a size-dependent cytotoxic cellular response but larger nanoparticles 
were non-toxic.[18] These results support the use of AuNPs in the development of safe and 
effective nanoparticle based therapies as the gold scaffold is viable for in vivo use since the 
surface chemistry may be easily controlled by installing biocompatible ligands on the surface 
for further bioconjugation and application.  
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The size and shape dependent optical properties of AuNPs are exploited the most in 
nanoparticle research for the design of novel therapeutic and diagnostic systems. AuNPs 
display surface plasmon resonance (SPR) absorption from collective resonant oscillation of 
the free electron cloud in the conduction band of the metal resulting in sharp absorption in the 
visible or near infrared range of the electromagnetic spectrum.[19] This physical property 
mainly depends on the size and shape of the AuNP but is also influenced by the surface 
chemistry. For example, in smaller AuNPs (< 10 nm) the SPR causes absorption in the blue-
green portion of the spectrum (~450 nm) resulting in a characteristic red wine color. But as 
the nanoparticle size increases (> 10 nm), the absorption wavelength shifts more to the red 
and the nanoparticle solution appears more blue in color (Figure 1.4). 
 
Figure 1.4: (Top) Colors of various sized monodispersed AuNP in solution (Bottom) TEM 
images of various sized monodispersed AuNP. The diameter increases from left to right. 
Images from Sigma-Aldrich product information website.[20] 
By simply examining the UV-Vis spectrum of AuNP solutions such as the ones in 
Figure 1.4, the SPR can be readily observed as a sharp absorption in the visible or near infrared 
range. The size-dependence of the SPR absorption is demonstrated in the UV-Vis spectra 
below (Figure 1.5). First, it is important to note that small nanoparticles do not exhibit a 
plasmon because they are better treated as molecular clusters with discrete electronic states.[21] 
But as the AuNP diameter increases from 20 nm to 100 nm, the wavelength of maximum 
absorption (the plasmon) also increases. For even larger nanoparticles, the plasmon shifts into 
the near infrared (NIR) region. In addition, light is not able to polarize the larger particles 
homogeneously so the plasmon appears quite broad. [21] 
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Figure 1.5: UV-Vis spectra of various sized AuNPs. Image from Cytodiagnostics product 
information website.[22] 
Much research has been devoted to exploiting the SPR to serve as a powerful 
analytical, diagnostic and therapeutic tool. The dependence of the optical properties of 
spherical AuNPs on particle size and wavelength were analyzed theoretically using multipole 
scattering theory and compared to experimental results.[23] AuNPs ranging in size from 5 to 
100 nm were synthesized and characterized by TEM and UV-Vis and the results were in 
excellent agreement with the theoretical calculations. As a result, the size and concentration 
of spherical and monodisperse AuNPs in solution can be simply determined with UV-Vis data. 
The authors compiled a series of tables to summarize their findings providing a simple and 
fast method to determine size and concentration of AuNPs. However, this method is limited 
by the fact that experimental data consists of a distribution of sizes and shapes that are not 
perfectly spherical or monodisperse. In addition, because the SPR is also influenced by the 
surface chemistry, a shift in the wavelength of maximum absorption in the UV-Vis spectra 
indicates successful surface functionalization or conjugation. For spherical AuNPs, a minor 
red shift of less than 5 nm is typically observed after surface functionalization which can serve 
as an analytical tool for identifying whether functionalization was successful or not.  
AuNPs also have the ability to resonantly scatter visible and near-IR light at 
frequencies coinciding with the particles’ surface plasmon resonances.[24] The light is scattered 
most strongly at the wavelength of the SPR maximum and is extremely sensitive to the size 
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and shape of the particles. As such, preliminary studies have reported the use of large AuNPs 
as contrast agents for biomedical imaging. AuNPs also possess several advantages compared 
to other cellular imaging agents. First, they scatter light intensely and are much brighter than 
small molecule chemical fluorophores. Also they do not photobleach and can be easily 
detected at very low concentrations up to 10-16 M.[25] El-Sayed et al.[26] were able to distinguish 
between cancerous and non-cancerous cells by conjugating anti-epithelial growth factor 
receptor (EGFR) antibodies to AuNPs as most cancerous cells express significantly higher 
amounts of EGFR. The anti-EGFR antibody conjugated AuNPs were able to bind to the 
surface of cancer cells with 600% greater affinity compared to non-cancerous cells. As a result 
of the strong resonant light scattering ability, it was possible to image the cells with improved 
contrast. As a control, non-conjugated AuNPs were also investigated and found to accumulate 
inside the cells. Anti-EGFR antibody conjugated AuNPs bound specifically to the surface of 
cancerous cells and non-specifically to noncancerous cells. In addition, upon specific binding 
to the EGFR on the cell surface of cancerous cells, the plasmon was red-shifted compared to 
anti-EGFR AuNPs in solution. The magnitude of the plasmon shift was larger and could be 
differentiated for non-specific binding in non-cancerous cells. As a result, both SPR scattering 
imaging and SPR absorption spectroscopy could be used as a diagnostic tool in cancer 
diagnosis for differentiating between cancerous and non-cancerous cells.  
In addition to the tunable light absorption and scattering properties useful for imaging, 
AuNPs can also convert the absorbed light into heat via a series of non-radiative processes 
leading to an increase in temperature within the lattice on the order of a few tens of degrees.[27] 
The lattice may then cool off by transferring the thermal energy to the surrounding medium 
resulting in the heat-up of the surrounding medium. However, depending on the energy source 
used, it is also possible to induce structural changes or melting to the particle as a result of the 
heat generated. To avoid this, continuous wave lasers are used to allow for heat dissipation 
from particles to the surrounding medium. High energy pulsed lasers typically produce 
unwanted structural changes as a result of the strong excitation in a short amount of time.[28] 
Thus AuNPs have been investigated in the literature as therapeutic agents for photothermal 
therapy (PTT) in cancer treatment. In a study by El-Sayed et al., targeted 40 nm AuNPs were 
able to induce cancer cell damage.[29] However, a disadvantage of spherical particles for use 
in PTT is that the absorbance peak is in the visible region so it is only suitable for shallow 
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cancers such as skin cancer. For in vivo PTT of tumors deep within tissue, NIR light is required 
because of its deep penetration due to minimal absorption from hemoglobin and water 
molecules within this spectral region.[27] As a result, gold nanorods have received more 
attention in the literature as PTT agents because of strong absorption in the NIR region.[30] 
1.3#Synthesis#of#AuNPs#
Over the past few decades, many synthetic methods have been developed in order to 
gain control of the size, shape and surface properties of AuNPs. Their synthesis typically 
begins in the liquid phase by the reduction of the gold salt tetrachloroauric acid (HAuCl4) 
leading to nucleation and formation of nanoparticles. In order to prevent aggregation as they 
form, the nanoparticles are stabilized with a ligand corona. In some syntheses, the stabilizing 
layer also terminates further growth. Each synthetic approach has its own advantages and 
limitations in regards to control over the physical properties of the resulting AuNPs. The 
following methods are best tailored for the synthesis of spherical AuNPs and can be optimally 
selected to achieve a desired size.[31]  
One of the most common methods was developed by Turkevich et al. in 1951[32] and 
later refined by Frens et al. in the 1970s[33]. As described in Figure 1.6, it involved the reaction 
of HAuCl4 with citric acid in boiling water where the citrate ions act as both the reducing and 
stabilizing agent. Frens was able to refine this method by changing the ratio of gold to citrate 
in order to control the particle size. This fast and reliable procedure has been widely used to 
prepare spherical AuNPs with diameters between 10-50 nm but larger AuNPs up to the 100 
nm range can also be prepared with good control over the size distribution. During the 
reaction, the nucleation phase can be visually observed by a change in color from clear to dark 
blue after ~30 s of boiling after the two reagents have been added. The growth phase can then 
be seen by a change in color to bright red after ~90 s. But despite being the most common 
synthetic method, the use of the resulting citrate-stabilized AuNPs is limited. First, it is 
difficult to isolate them from the aqueous solution so characterization is problematic. Second, 
the stability of the ligand shell is minimal in regards to changes in pH or ionic strength of the 
solution. Finally, their functionalization is challenging as larger AuNPs have a higher 
tendency to irreversibly aggregate due to increased Van der Waals forces and derivatization 
of the carboxylic acid ligand shell is extremely limited. 
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Figure 1.6: Citrate-stabilized AuNPs prepared by the Turkevich method with HAuCl4 and 
sodium citrate in aqueous solution under reflux conditions where citrate acts as both the 
reducing agent and stabilizing ligand. 
In the early 1990s, Brust and Schriffin developed a direct synthesis method for 
alkanethiol-stabilized AuNPs.[34] Using a two-phase reaction, aqueous HAuCl4 is transferred 
to the organic phase (toluene) using the phase transfer reagent tetraoctylammonium bromide 
(TOAB). Then upon addition of a thiol to the organic phase, the gold (III) salt is reduced to a 
gold (I)-thiol polymer. This step can be visually observed by a discoloration of the organic 
phase from orange to clear and colorless. Sodium borohydride (NaBH4) is then added to as 
the reducing agent to give the final AuNPs where the oxidation state of gold is zero (Figure 
1.7, left). This protocol gives spherical AuNPs with low size and shape dispersity in the 1 to 
5 nm range depending on the reaction conditions used. The size of the resulting AuNPs can 
be tuned by varying the molar gold-to-thiol ratio, reaction temperature and reduction rate. For 
example, a larger thiol to gold ratio thiol results in smaller nanoparticles,[35] lower reaction 
temperatures decrease size polydispersity[36] and faster addition of the reducing agent gives 
smaller nanoparticles.[37] The Brust-Schiffrin method yields more stable AuNPs as a result of 
the strong gold-thiol bond previously described as well as van der Waals attractive forces 
between neighboring ligands. These AuNPs are also synthetically much easier to work with 
because they can be thoroughly dried and re-dissolved in common organic solvents without 
irreversible aggregation or ligand dissociation. This is very important in order to be able to 
perform post-synthetic modifications on the AuNP surface.  
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Figure 1.7: (Left) Brust-Schriffin two-phase synthesis of AuNPs by reduction of HAuCl4 
using alkanethiols as the stabilizing ligands and NaBH4 as the reducing agent. (Right) 
Modified one-phase Brust reaction scheme using methoxy terminated tri(ethylene glycol) thiol 
ligands. 
Over the years a number of modifications have been made to the Brust-Schiffrin 
approach to overcome limitations of the alkanethiolate stabilized AuNPs. First, these AuNPs 
are not soluble in water and therefore incompatible with biological systems. In addition, 
contamination of residual TOAB can influence potential applications of the AuNPs.[38] 
Although purification methods were developed, in the end they proved to be costly and time 
consuming. To overcome these problems, a one-phase method was developed to remove use 
of the phase transfer reagent and avoid contamination (Figure 1.7, right). To improve 
solubility in water, PEG based stabilizing ligands replaced the original alkane based ones. The 
first direct synthesis of oligo(ethylene glycol)-protected AuNPs was reported by Huang et 
al.[39] In recent years, our group has developed improved methodologies for the synthesis of 
methoxy terminated tri(ethylene glycol) based AuNPs.[40] These ligands contain an –(O-CH2-
CH2)- repeating unit and a terminal methoxy (-OCH3) group that decorates the nanoparticle 
surface and forms a densely packed monolayer in the ligand corona that stabilizes the AuNP. 
It also produces a more versatile system as the resulting nanoparticles are soluble in both 
aqueous and organic solvents.  
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In order to achieve even larger nanoparticles, a seeding growth method is required. 
This approach was discovered by Perrault and Chan in 2009.[41] It involves using 
hydroquinone as a mild reducing agent to reduce HAuCl4 in an aqueous solution that contains 
15 nm AuNP seeds. Typically, the nanoparticle seeds are produced using the citrate method. 
This method yields larger AuNPs (> 50 nm) with a greater size range as well as better size and 
shape dispersity. In summary, along with the other methods previously described, it is possible 
to synthesize AuNPs with a size range from 1 to 200 nms with homogeneous sizes and shapes 
for future biomedical applications.  
1.4#Functionalization#of#AuNPs##
The development of AuNPs modified with complex ligands containing a functional 
substrate (small molecule, polymer or biomolecule) is of very high interest. These functional 
AuNPs may then interact either chemically or physically with other substrates to perform a 
specific function such as act as a biological or chemical sensors. As previously described, 
there are three main strategies used for the preparation of functionalized AuNPs including (i) 
direct synthesis (ii) place (or ligand) exchange reactions (iii) post-synthetic interfacial 
reactions.  
 The direct synthesis of functional AuNPs involves the incorporation of a thiol 
containing complex ligand during AuNP synthesis to simultaneously provide stabilization as 
well as introduce functionality (Figure 1.8). However, this strategy is challenging as a result 
of the reaction conditions used for AuNP synthesis. For example, ligands containing 
functional groups that are easily reduced are incompatible with the sodium borohydride 
reducing agent used in the Brust-Schriffin method. In addition, the synthesis of such complex 
thiols can be very difficult and time consuming. 
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Figure 1.8: (Top) Direct synthesis of functional AuNP where the incorporation of a thiolated-
ligand possessing a functional substrate through a direct synthetic method can be quite 
challenging (Bottom) Indirect synthesis of functional AuNP where the incorporation of 
functional substrates is often possible using an indirect approach through a place exchange 
reaction.  
In order to avoid undesired reactivity with the functional substrate, an intermediate 
AuNP can be employed as a precursor and then transformed into a functional AuNP system. 
A versatile method for achieving this transformation is the place or ligand exchange reaction 
developed by Murray et al.[42] In the place exchange reaction, the ligands on the originally 
synthesized AuNPs may be readily exchanged with another thiolate ligand simply by exposing 
the AuNPs to a large excess of a thiol with the desired functionality. For example, following 
place exchange with Brust-Schriffin type AuNPs, the resulting AuNPs contain a mixed 
monolayer of both the original thiolate and functionalized thiolate ligands. The extent of 
ligand exchange that takes place can be controlled by the ratio of gold to thiol used as well as 
the reaction time. Large AuNPs produced by the Turkevich method may also undergo place 
exchange reactions due to the relatively weak binding between the AuNP surface and carboxyl 
groups on the citrate ions. 
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Finally, post-synthetic interfacial reactions may also be used to functionalize AuNPs 
through an organic reaction with a terminal functional group on the surface of the AuNP. This 
versatile strategy has led to the development of multifunctional AuNPs as terminal functional 
groups may react with a multitude of different substrates to introduce novel functionality. 
Although numerous approaches have been reported in the literature for the conjugation of a 
molecule of interest to a material surface by reaction with an endogenous[43] or exogenous[44] 
functional group, no single approach can be broadly adopted due to the vast complexity of 
substrates for application. As a result, there is a need for a simple and convenient system that 
allows for material surface functionalization but can also be modified depending on the 
substrate involved. So over the past few years, the Workentin group has developed a toolbox 
of sophisticated methods for the systematic functionalization of small (1-5 nm) water-soluble 
AuNPs through the design of AuNP templates (Figure 1.9). These templates contain a reactive 
functional group that is introduced to the AuNP surface through the methods previously 
described, but most commonly via a place exchange reaction. The latter method allows for 
better control over the loading of the functional ligand. The functional group introduced as a 
template may then undergo interfacial chemistry with a suitable reaction partner that contains 
a functional substrate. With this strategy, our group has been able to incorporate various 
functional groups and create a library of versatile AuNP templates to be able to introduce 
different structural diversity. For example, using maleimide-functionalized AuNPs as the 
template our group was able to develop a molecular delivery system via an interfacial 
glutathione-mediated retro Michael-type addition reaction.[45] Using the same AuNP template, 
our group was also able to develop an MRI contrast agent via an interfacial Michael addition 
with a gadolinium(III) chelate.[9] 
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Figure 1.9: Example of AuNP template design for the introduction of versatile functional 
substrates. 
For large AuNPs, carbodiimide-mediated bioconjugation is the most common 
interfacial reaction used for biofunctionalization but it usually leads to a loss of colloidal 
stability depending on the polymer used for stabilization. The development of novel 
carbodiimide reagents has been explored in order to address this issue[46] but the scope of 
interfacial chemistry for the functionalization of large AuNPs remains quite limited in the 
present literature. 
1.5#Interfacial#Bioorthogonal#Click#Chemistry#
The familiar term “click chemistry” was first introduced by Sharpless and describes a 
set of reactions that are fast, stereo- and chemoselective and high yielding.[47] Most notably, 
the copper(I)-catalyzed alkyne−azide cycloaddition (CuAAC), has become one of the most 
reliable click reactions as evidenced by its common practice in materials chemistry[48] and 
chemical biology[49] for covalently connecting molecules via the formation of a trizaole ring. 
However, the in vivo applications are limited due the cytotoxic nature of the copper catalyst 
as the presence of the metal ions may damage or destroy oligonucleotides.[50] To overcome 
these limitations and exploit this class of chemistry in biological systems, a non-cytotoxic 
subset was developed and termed “bioorthogonal click chemistry”. Lately, the strain-
promoted alkyne-azide cycloaddition (SPAAC) reaction has emerged and occurs with very 
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fast reaction kinetics as well as high efficiency and chemoselectivity. Strained alkynes can 
undergo even more rapid strain-promoted cycloaddition with nitrones in the strain-promoted 
alkyne-nitrone cycloaddition (SPANC) reaction.[51] The driving force of these reactions 
originates from the strain resulting from the non-linear geometry of the alkyne. The key feature 
in these strain promoted cycloaddition reactions is the elimination of the metal catalyst that is 
required for the traditional alkyne-azide click reactions so as a result the SPAAC and SPANC 
reactions have been viable for use in living systems.[52] The Workentin group has taken 
advantage of this class of reactions by designing AuNP templates for interfacial bioorthogonal 
click chemistry (Figure 1.10). Our group was the first to introduce strained alkyne 
functionality onto AuNPs and demonstrate interfacial SPAAC.[53] The incorporation of a 
variety of other bioorthogonal functionalities to the AuNP surface has also been achieved such 
as azides and nitrones.. We have also demonstrated an interfacial Staudinger-Bertozzi 
ligation[54]
 
in addition to 1,4 Michael- type additions[55] and Diels-Alder cycloadditions with 
maleimides. Our group aims to continue developing new click and bioorthogonal AuNP 
templates for interfacial functionalization and this is one of the focuses of my thesis.  
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Figure 1.10: The Workentin group AuNP toolbox. Reaction schemes of click and 
bioorthogonal functional groups incorporated into AuNP templates. 
 
Recently, the Popik group has developed a photochemically triggered click reaction 
system for facile and efficient hetero-Diels-Alder as well as Michael addition (Scheme 1.1).[56] 
Photochemical dehydration of 3-hydroxy-2-naphthalenemethanol derivatives by irradiation 
with UV light (350 nm) produces ortho-naphthoquinone methides (oNQMs). The resulting 
molecule is able to undergo facile cycloaddition to produce photostable Diels-Alder adducts. 
In aqueous solution, unreacted oNQM is rapidly hydrated to regenerate the naphthoquinone 
methide precursor (NQMP) starting material. The competition between hydration and 
cycloaddition makesoNQMs highly selective as only vinyl ethers and enamines arereactive 
enough to form the Diels-Alder adduct in aqueous solution. No cycloaddition is observed with 
other types of alkenes.[57] Instead, the hydration product is recovered demonstrating the 
selectivity of the reaction. More importantly, oNQMs may also undergo Michael addition with 
various nucleophiles including thiols. The resulting thioether is hydrolytically stable, but it 
can be quantitatively cleaved photochemically under 300 or 350 nm irradiation back to oNQM 
with a 10% quantum yield.[58] Additionally, although oNQM compounds are reportedly 
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cytotoxic as a result of undesirable side reactivity to alkylate DNA bases, in this system the 
oNQM functionality is formed photochemically and therefore viable for in vivo use.[57] The 
focus of Chapter 2 in this thesis is the development of a novel AuNP template that contains 
this highly desirable click and bioorthogonal functionality. The light activation and 
reversibility will allow for unprecedented temporal and spatial control of reactivity for 
patterning and delivery. 
 
Scheme 1.1: Photochemical generation and reactivity of oNQM from NQMP in aqueous 
solution. 
1.6#Characterization#of#AuNPs#
The characterization of as-synthesized small AuNPs may be completed with a variety 
of imaging and spectroscopic techniques. Advantageously, the introduction of bioorthogonal 
functional groups to the AuNP interface may also be characterized by common spectroscopic 
techniques in order to determine the loading capacity (number of bioorthogonal functionalities 
incorporated) as well as investigate reactivity. TEM is most commonly used in order to 
determine the size and shape characteristics of AuNPs. TEM is a microscopy technique in 
which a beam of electrons is transmitted through a sample of interest to form an image. Using 
this technique, it is possible to not only directly visualize the AuNP core but also extract 
information about their shape (spherical, nanorods, nanostars, etc.) as well as their size 
dispersity through a direct measurement. However, it is not possible to gain information about 
ligand composition because of the low electron density within the corona. Examples of TEM 
images of various types of nanoparticles are included in Figure 1.2.  
Nuclear magnetic resonance (NMR) spectroscopy is one of the most powerful tools 
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for obtaining significant information about the composition and structure of the ligands on the 
AuNP surface.[59] The solubility of Brust-Schiffrin type small AuNPs in both organic and 
aqueous solvent is very amenable to 1H NMR analysis but citrate-stabilized AuNPs are more 
difficult. The signals in the 1H NMR spectrum of functionalized AuNPs corresponding to 
ligands on the AuNP surface appear broad. The broadness is due to the inhomogeneous AuNP 
surfaces and Au-S bonding sites resulting in slightly different chemical shifts. In addition, 
slow rotation of the thiolates bound to the AuNP core induces a very fast spin-spin relaxation 
(T2) that also contributes to broadening.[60] Nevertheless, 1H NMR spectroscopy may still be 
used to investigate the successful functionalization and purity of AuNPs. For example, after a 
place exchange reaction, the presence of free ligand appears as sharp signals in the 1H NMR 
spectrum. On the other hand, ligands bound to the AuNP core will appear at the same chemical 
shift as their non-bound counterparts, however the signals will be much broader for the reasons 
previously described. Subsequent interfacial chemistry may also be monitored through 1H 
NMR spectroscopy in the same manner as conventional small molecule chemistry.  
The synthesis of large citrate-stabilized AuNPs in water limits the use of 1H NMR 
spectroscopy as a characterization tool. However, since the Turkevich method produces larger 
AuNPs (> 5 nm) that exhibit a surface plasmon, it is possible to take advantage of this unique 
optical property for characterization. Spherical AuNPs exhibit a strong size-dependent 
absorption peak in the visible range. As a result, by analyzing the wavelength of maximum 
absorption it is possible to determine the approximate AuNP core size in excellent agreement 
with data obtained from imaging techniques such as TEM.[23] The peak absorbance 
wavelength also shifts to the NIR region for uneven shaped nanoparticles so it is also possible 
to obtain information about the shape of the nanoparticles. In addition, the plasmon is also 
influenced by the surface chemistry of the AuNP. A shift in the wavelength of maximum 
absorption in the UV-Vis spectra can be used to indicate surface functionalization. Typically, 
a minor red shift of less than 5 nm is observed for spherical AuNPs after surface 
functionalization.[61] 
Finally, after determining the gold core size through microscopic or spectroscopic 
techniques, the number of ligands with respect to the number of gold atoms on the AuNPs, 
can be easily determined using thermogravimetric analysis (TGA).[62] TGA measures the 
changes in the weight of a sample as a function of temperature and/or time under a controlled 
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atmosphere such as nitrogen. As the temperature increases, the organic ligands are removed 
from the nanoparticle surface and vaporized. The corresponding mass loss associated with this 
stage indicates the percentage of organic ligands contained on the surface of the AuNPs.  
1.7#Objectives#–#Chapter#2#
The goal of this project was to develop a novel photoreactive AuNP-NQMP 
functionalized template that upon irradiation by UV light undergoes fast, selective and 
photoreversible Michael addition. The overall synthetic strategy is outlined in Scheme 1.2. 
First, the introduction of oNQM functionality onto a AuNP template requires the synthesis of 
a thiolated NQMP ligand. Chapter 2 describes the synthetic strategy for producing this ligand 
in good yield as well as characterization of all intermediates by 1H NMR, 13C NMR and IR 
spectroscopy as well as mass spectrometry (MS). Then a place exchange reaction of the 
proposed ligand using methoxy-terminated AuNPs was accomplished to yield NQMP 
functionalized AuNPs. This novel AuNP-NQMP template provides a selective and versatile 
template for interfacial chemistry with spatial and temporal control of reactivity through UV 
irradiation. My addition to the Workentin AuNP toolbox was fully characterized through 1H 
NMR, IR, and UV-Vis spectroscopy as well as TGA and TEM. These novel AuNPs will then 
be able to undergo interfacial Michael addition reactions that are also photoreversible. This 
unique system will expand the scope of the AuNP toolbox by introducing a novel click and 
photoreversible functional group with remarkable temporal and spatial control of reactivity 
for the design of delivery systems. 
 
Scheme 1.2: Outline of synthetic strategy for the synthesis of oNQM-AuNP and 
photoreversible interfacial Michael Addition.  
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1.8#Objectives#–#Chapter#3#
Another goal of my M.Sc. research was to transpose the toolbox of reactions onto 
larger AuNPs in order to take advantage of their unique optical properties. Larger AuNPs 
display SPR absorption resulting from collective resonant oscillation of the free electron cloud 
of the conduction band of the metal resulting in sharp absorption in the visible[21] or near-
infrared[63] range. Large AuNPs also exhibit excellent scattering properties The strongly 
absorbed light can also be converted to heat so larger AuNPs have been utilized for imaging 
and PTT[27, 29]. An interesting alternative application of the photothermal effect could be to 
provide energy for interfacial chemistry to enable faster and more efficient functionalization 
of the AuNP surface.  
However, the synthesis of large AuNPs that are stable and water-soluble remains 
challenging as they have a higher tendency to aggregate due to increased Van der Waals forces 
so the ability to further exploit the SPR for in vivo applications is limited. In the current 
literature, polyethylene glycol (PEG) is commonly used for stabilization but as a result of its 
polydispersity (non-uniform polymer lengths), it is difficult to characterize and functionalize 
the final AuNP. The dilemma presented in the literature is that high molecular weight PEG 
provides excellent stability but poor conjugation ability. On the other hand, low molecular 
weight PEG enables high conjugation ability but provides minimal stability resulting in 
irreversible aggregation, especially for larger AuNPs. In order to address this issue, Liu et al. 
reported a simple method using mixed PEG layers with specific ratios of low and high 
molecular weight PEG.[64] Through characterization by X-ray Photoelectron Spectroscopy 
(XPS), successful bioconjugation of proteins and monoclonal antibodies was then 
demonstrated without detectable aggregation. However the scope of PEG stabilized AuNPs is 
limited because the tight PEG-thiol AuNP monolayer inhibits place-exchange reactions with 
other thiols[65] thereby restricting the introduction of more chemically interesting functional 
groups for interfacial chemistry. 
In order to expand the scope of large AuNPs for biomedical applications, it is necessary 
to circumvent the PEG dilemma by designing hydrophilic ligands of discrete size that still 
provide excellent stability to the large gold core as well as a high loading capacity. In this 
fashion, it will be possible to functionalize and characterize the final large AuNP through 
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conventional small NP techniques such as NMR spectroscopy. The structure of the proposed 
model ligand is described in Figure 1.11. It is derived from three unique fragments such that 
the final ligand highlights three important features. First, the gold core may be stabilized 
through thiol binding at the head. At the tail, the model ligand contains a methoxy-terminus 
that could be replaced with a bioorthogonal functionality as described in Figure 1.10 to 
undergo click and biorthogonal interfacial chemistry. Finally, the number of repeating units 
(n) may be systematically increased to provide further stabilization and account for increased 
AuNP core size. In addition, it is predicted that these ligands will form a network of hydrogen 
bonding shells around the gold core for increased stabilization and hydrophilicity[66]
 
as 
described in Figure 1.12. A major factor in the stability of the AuNPs is the repulsive forces 
that occur between the ligands, which is induced by electrostatic repulsion and steric effects. 
To overcome this obstacle, the amide hydrogen bonding pattern will allow for lateral hydrogen 
bonding between ligands in the AuNP monolayer to further stabilize the corona. 
 
 
Figure 1.11: Retro-synthesis of the model ligand (n = 1) and highlighted features. 
In the end, AuNPs ranging from 20 to 50 nm were synthesized by the Turkevich 
method and stabilized by these novel ligands to yield functionalizable water-soluble AuNP 
templates of varying size. The required novel ligand was synthesized through a convergent 
approach as described in Figure 1.11. The formation of hydrogen bonding shells within the 
ligand corona will provide sufficient stabilization eliminating the use of polymeric ligands that 
are conventionally used. By using an oligomeric ligand of discrete size, it will also be possible 
to achieve a high loading capacity without aggregation. Then once the final AuNP template is 
made, the synthetic approach can be modified to incorporate the AuNP toolbox and introduce 
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click and bioorthogonal functionalities to the AuNP surface for fast, clean and efficient 
interfacial chemistry. The overall design is described in Figure 1.11.  
 
Figure 1.12: Design of novel ligand with hydrogen bonding shells. The tail may be replaced 
with bioorthogonal functional groups. 
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CHAPTER(2(
 
2.1$Introduction$
 
Functionalized AuNPs have demonstrated promising applications in biomedicine,[1] 
drug delivery and sensing technology[2] by introducing functionalities through interfacial 
chemistry. As previously described in Figure 1.10, our group has made significant efforts 
towards the synthesis of small water-soluble AuNP templates that can undergo click and 
bioorthogonal interfacial chemistry for post-synthetic modification of the gold core. Among 
all nanomaterials, AuNPs are often regarded as the most promising template for biomedical 
applications as they feature low toxicity, chemical stability, and high loading capacity because 
of high surface area-to-volume ratio. In addition, the optical and chemical properties of AuNPs 
can be tuned by varying the gold core diameter and composition of the ligand corona, 
respectively. Chapter 2 presents the synthesis of a novel ortho-naphthoquinone methide 
(oNQM) functionalized small AuNP template that can undergo light-induced Hetero-Diels-
Alder cycloadditions[3] and reversible photochemical Michael addition[4] (Scheme 1.1). Popik 
et al. have extensively studied the photochemical properties of 3,5-dihydroxy-2-naphthoic 
acid[5] and demonstrated its use for the modification of surfaces[6] and proteins.[4] As described 
in Scheme 2.1, the introduction of oNQM functionality is achieved via place exchange onto 
methoxy terminated AuNPs which requires the synthesis of a thiol-modified NQMP ligand. 
Commercially available 3,7-dihydroxy-2-naphthoic acid was selected as the starting material 
in order to potentially minimize steric crowding within the ligand corona of the final AuNP. 
The synthetic protocol towards the NQMP modified ligand is described herein as well as the 
characterization of synthetic intermediates by 1H NMR spectroscopy, 13C NMR spectroscopy, 
IR spectroscopy and MS. The final ligand was also characterized by UV-Vis spectroscopy to 
investigate its photochemical properties. This interesting photochemical functional group was 
then successfully introduced onto a AuNP surface for the first time via a place exchange 
reaction. The resulting NQMP-functionalized AuNPs were characterized by 1H NMR, IR and 
UV-Vis spectroscopy as well as TGA and TEM. This novel AuNP template expands the scope 
of the Workentin AuNP toolbox as a result of its versatile reactivity profile including reversible 
photochemical reactivity.  
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Scheme 2.1: Reprinted from Chapter 1. Synthetic strategy for synthesis of NQMP 
functionalized AuNPs and its proposed reactivity as a novel template. 
 
2.2$Results$and$Discussion$
 
2.2.1$Synthesis$and$Characterization$of$HS;EG4;NQMP$
The synthesis of the thiolated NQMP ligand is outlined in Scheme 2.2. First, 
tetraethylene glycol (compound 2.1) was mono-tosylated (compound 2.2) to provide a better 
leaving group for subsequent thioacetate substitution (compound 2.3). The hydroxyl functional 
group was then substituted with an iodine to give compound 2.4. In parallel, the carboxylic 
acid of the starting material 2.5 was reduced to the corresponding primary alcohol. The 
resulting diol 2.6 was then protected with an acetonide protecting group to give compound 2.7. 
In order to achieve higher yields, 4 Å molecular sieves were used to remove water and 
methanol formed during the reaction. The resulting compounds 2.4 and 2.7 were then refluxed 
under basic conditions to give the coupled intermediate 2.8. The reaction sequence then 
involved cleavage of the acetonide protecting group to re-form the diol (compound 2.9). 
Finally, the thiol functionality was formed by hydrolysis of the thioacetate protecting group to 
give the final ligand compound 2.10. It is important to note that all synthetic procedures 
involving the photosensitive NQMP functionality were performed in the dark to minimize 
potential photoreactivity.  
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Scheme 2.2: Synthesis of HS-EG4-NQMP.  
 
The characterization of all compounds in Scheme 2.2 was completed with 1H NMR, 
13C NMR and IR spectroscopy as well as mass spectrometry. The characterization of 
compound 2.2 was in agreement with previously reported data. Subsequent thioacetate 
substitution in compound 2.3 could be tracked by 1H NMR spectroscopy through the 
appearance of a singlet at 2.34 ppm (3H) corresponding to the terminal methyl group. The 13C 
NMR spectrum also revealed a carbonyl signal at 195.6 ppm. Following iodination to give 
compound 2.4, the protons alpha to the iodine experienced an upfield shift to 3.27 ppm. The 
IR spectrum of compound 2.4 also revealed the disappearance of a large OH stretch. In parallel, 
3,7-dihydroxy-naphthoic acid (compound 2.5) was reduced to the corresponding primary 
alcohol to give compound 2.6 and fully characterized. The 1H NMR spectrum showed five 
signals in the aromatic region in addition to a diagnostic singlet at 4.77 ppm corresponding to 
the benzylic protons. Although compound 2.6 has been previously synthesized through a 
different synthetic route,[7] it is still interesting to inspect the complex splitting pattern observed 
in the aromatic region. All five protons can be assigned by simply calculating the coupling 
constants and analyzing resonance structures (Figure 2.1). The doublet of doublets at 6.98 ppm 
(HA) is the most interesting signal in the spectrum as it is easy to extract two coupling constants 
of different magnitudes. The larger coupling constant may be assigned to the 3JA-C interaction 
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whereas the smaller coupling constant must therefore arise from the 4JA-B interaction. The 
remaining singlets can be assigned by resonance. HE is shielded by resonance so consequently 
HD must be the more downfield signal.  
 
Figure 2.1: 1H NMR spectrum of aromatic region of HO-NQMP. 
 
The photosensitive diol in intermediate 2.6 was then protected with an acetonide 
protecting group by reaction with 2,2-dimethoxypropane in acetone. It is interesting to note 
that in the mechanism of this reaction, either the reagent or the solvent may be used to form 
the protecting group. To aid the progress of the reaction, 4 Å molecular sieves were added to 
remove excess water and methanol released during the reaction. The acetal could be 
characterized by the appearance of a large singlet at 1.54 ppm integrating to 6H. Compounds 
2.5 and 2.7 were then coupled together through a substitution reaction to give compound 2.8. 
In the 1H NMR spectrum of compound 2.8, the expected ethylene glycol and NQMP aromatic 
signals were observed. Once the thiol functionality was installed onto the NQMP, the acetal 
protecting group could be cleaved by treatment with an acidic Amberlyst resin to give 
compound 2.9 in good yield. Upon reformation of the diol, the chemical shift of the benzylic 
NQMP protons shifted upfield and the large singlet corresponding to the acetal protons 
disappeared. Finally, the thioacetate protecting group could be removed by treatment with base 
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to give the final ligand 2.10. It is important to note that in order to avoid formation of disulfide, 
the hydrolysis must be performed in the absence of oxygen. As a result, all reagents were 
carefully placed under a positive pressure of argon gas prior to reaction. The thiol 2.10 was 
successfully characterized by 1H NMR spectroscopy by the disappearance of the terminal 
acetate signals as well as the appearance of a triplet at 1.58 ppm corresponding to the SH. The 
protons alpha to the thiol functionality are also diagnostic of the presence of a thiol as the signal 
is split into a doublet of triplets.  
The synthesis of ligand 2.10 was also attempted using a trityl protecting group for the 
thiol but it was unsuccessful. The synthesis was carried through to the trityl analogue of 
compound 2.9 but it was not possible to isolate the thiol. All experimental results and spectral 
data are included in the Experimental and Appendix sections of this chapter. 
 
 
Figure 2.2: 1H NMR spectrum of HS-EG4-NQMP in CDCl3. * denotes residual protonated 
solvent signals or solvent impurities. 
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Compound 2.10 was also characterized by IR spectroscopy (Figure 2.3). First, the thiol 
SH gave a very weak signal at 2550 cm-1. Then in addition to the Csp3-H stretch, the IR 
spectrum also revealed two broad signals above 3000 cm-1, characteristic of OH stretches.  
 
Figure 2.3: IR spectrum of HS-EG4-NQMP. 
 
2.2.2$Synthesis$and$Characterization$of$AuNP;EG4;NQMP$
 
AuNP-EG4-NQMP were prepared through a place-exchange reaction of NQMP 
modified thiol 2.10 onto triethylene glycol monomethyl ether AuNPs (AuNP-EG3-OMe) in 
CH2Cl2 at room temperature (Scheme 2.3). AuNP-EG3-OMe were synthesized according to a 
protocol previously developed by our group to afford AuNPs with a gold core diameter of 3 
±1 nm as determined by TEM measurements.[8] The composition of the ethylene glycol ligand 
corona also provides both organic solvent and water solubility. In addition, these AuNPs are 
resistant to both acidic and basic conditions, can be heated to over 100 °C, and can be 
repeatedly dried and redissolved in solvent with little to no aggregation. As a result, they are 
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very resilient substrates for further modification including place exchange and subsequent 
interfacial organic chemistry. 
After 2 h of place exchange under vigorous stirring in the dark, the solvent was 
evaporated and the NQMP modified-AuNPs were purified from excess thiol by re-dissolving 
in ethyl ether (Et2O) in which the AuNPs are not soluble. The supernatant containing excess 
thiols and disulfides was removed and the entire washing procedure was repeated six times 
overall to afford clean AuNP-EG4-NQMP. These AuNPs were characterized by 1H NMR, 
infrared (IR) and UV-Vis spectroscopy as well as by transmission electron microscopy (TEM) 
and thermogravimetric analysis (TGA).  
 
Scheme 2.3: Place exchange of ethylene glycol monomethyl ether AuNPs to NQMP 
functionalized AuNPs. 
 
The 1H NMR spectrum of AuNP-EG4-NQMP showed the presence of broad peaks 
corresponding to incorporation of NQMP thiol ligand 2.10 as well as the triethylene glycol 
monomethyl ether ligand (Figure 2.4). As previously described in Chapter 1, the broadening 
of signals in the 1H NMR spectrum is commonly observed in AuNP surface analysis by NMR 
spectroscopy. The 1H NMR spectrum of AuNP-EG4-NQMP also indicates that the washing 
procedure was effective in removing unbound thiols and disulfides as there are no sharp signals 
present. After only three washes with Et2O, the 1H NMR spectrum revealed sharp signals 
overlaying the broad signals so a total of six washes were required to completely remove excess 
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thiol. It is worth noting that the removal of unbound thiols is important in successfully 
synthesizing oNQM functionalized AuNPs as any remaining thiol could undergo nucleophilic 
attack of the Michael acceptor following the photochemical dehydration step. This would result 
in a loss of control over the desired reactivity. Comparison of 1H NMR spectra of thiol 2.10 
and AuNP-EG4-NQMP showed good correspondence of peaks at 7.55, 7.13, 4.91, 4.17 ppm, 
which confirmed successful synthesis of AuNP-EG4-NQMP. In particular, the signal at 4.91 
ppm corresponding to the benzylic protons of NQMP is well-resolved diagnostic of successful 
NQMP introduction.  
The approximate amount of NQMP ligand incorporated after place exchange may also 
be calculated from the 1H NMR spectrum. Aside from the methylene protons that produce a 
broad signal at approximately 3.62 ppm, the characteristic peak of AuNP-EG3-OMe is at 3.36 
ppm corresponding to the terminal methoxy group. In the 1H NMR spectrum of AuNP-EG4-
NQMP, by setting the integral at 3.36 ppm (-OCH3) to 100 and then integrating the signal at 
4.91 ppm (-CH2-OH) it is possible to determine the relative amount of NQMP modified ligand 
vs. triethylene glycol monomethyl ether ligand as follows: 
 !"#$%&'()*+)3.36)//0)12%"'() – 4567 = )100 !"#$%&'()*+)4.91)//0)12%"'() – 56= = )22 
Therefore, 
 100) 2"#$%&'()*+)3.36)//0)12%"'(3) – 4567 ) ≈ 33) '"@ )22)(2"#$%&'()*+)4.91)//0)12%"'()2) – 56= ) ≈ 11 
 
Under the reaction conditions used for the place exchange reaction, the ratio of OMe 
terminated ligand to NQMP functionalized ligand is 3:1 or approximately 25% NQMP 
incorporation.  
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Figure 2.4: 1H NMR spectra of HS-EG4-NQMP (top) and AuNP-EG4-NQMP (bottom) in 
CDCl3. The absence of sharp signals in the bottom spectrum indicates that no free ligand is 
present. * denotes residual protonated solvent signals or solvent impurities. 
 
The IR spectrum of AuNP-EG4-NQMP revealed a broad OH stretch at 3362 cm-1 
corresponding to the two hydroxyl functional groups in the NQMP functionality as described 
in Figure 2.3. In comparison to the IR spectrum of AuNP-EG3-OMe in Figure 2.5, it is clear 
that the ligand 2.10 was successfully incorporated onto the AuNP surface. 
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Figure 2.5: IR of AuNP-EG3-OMe (A) and AuNP-EG4-NQMP (B). 
 
The UV-Vis spectrum of HS-EG4-NQMP was also in agreement with previously 
reported results.[4] The 3-hydroxy-2-naphthalenemethanol chromophore has two major 
absorption bands in the UV region at CDEF = 275)"0 and CDEF = 324)"0. The introduction 
of an alkoxy substituent at the 7-position of the chromophore (compound 1.10) resulted in a 
shift for both bands to CDEF = 260)"0 and CDEF = 342)"0. Successful incorporation of 
NQMP onto the AuNP surface could also be characterized by UV-Vis spectroscopy as 
described in Figure 2.6. In comparison to the UV-Vis absorption trace of AuNP-EG3-OMe, the 
NQMP functionalized AuNPs exhibited absorbance at similar wavelengths as the free ligand 
2.10. As a result, the AuNP-EG4-NQMP template is suitable for activation to AuNP-EG4-
oNQM by irradiation using a 350 nm fluorescent lamp. 
 
B) A) 
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Figure 2.6: UV-Vis absorption spectra of HS-EG4-NQMP ligand, methoxy terminated AuNPs 
and NQMP modified AuNPs in CH3OH at different concentrations. 
 
Thermogravimetric analysis of AuNP-EG4-NQMP showed an overall 39.7% mass loss 
corresponding to the organic corona of the AuNPs, i.e. MeO-EG3-S- and NQMP-EG4-S- 
(Figure 2.7, left). In addition, the derivative of the TGA curve showed that there are two ligands 
present that decompose at distinctly different temperatures (Figure 2.7, right). As in previously 
reported systems by our group, the MeO-EG3-S- ligand decomposes at 280 °C.[8] Therefore, 
the component at 380 °C was assigned to the NQMP-EG4-S- ligand. By integrating the area 
under each curve in the derivative plot, it is also possible to determine the relative amounts of 
each ligand present. Through conversion to a molar ratio, it was found that under the reaction 
conditions used for the place exchange reaction (see Experimental), the AuNP surface was 
made up of approximately 20% of the NQMP ligand. This value is in close agreement in 
comparison to the value previously determined by 1H NMR analysis. The amount of ligand 
incorporated onto the AuNP surface may be improved by increasing the of ratio thiol to gold 
used as well as increasing the reaction time. Conversely, decreasing the ratio of thiol to gold 
or decreasing the reaction time would decrease the relative amount of NQMP ligand introduced 
to the AuNP surface. Further investigations into the place exchange reaction of this AuNP 
system would enable for tuning of the solubility properties.  
!! !
37 
 
Figure 2.7: (A) TGA plot (B) Derivative plot (dotted black line) of AuNP-EG4-NQMP. The 
green traces represent the fitted peaks and the red trace represents the sum of the fitted peaks. 
 
The TEM analysis of AuNP-EG4-NQMP compared to AuNP-EG3-OMe also showed 
no significant change in regards to the size or shape of the gold core following the place 
exchange reaction. As seen in Figure 2.8, there does not appear to be any significant difference 
between images of AuNP-EG3-OMe and AuNP-EG4-NQMP. This is an indication that the 
NQMP functionalized nanoparticles are stable and do not aggregate under the reaction 
conditions used.  
 
 
Figure 2.8: TEM images of AuNP-EG3-OMe (A) and AuNP-EG4-NQMP (B). The scale bar 
is indicated in each image.  
 
B) A) 
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2.3$Conclusion$
 
The goal of the work presented in Chapter 2 was to expand the scope of the Workentin 
AuNP toolbox (Figure 1.12) by the addition of a photoreversible click reaction. A thiolated 
NQMP ligand with a tetra(ethylene glycol) spacer was synthesized through a selective 
deprotection strategy in good yield. All synthetic intermediates were characterized by NMR 
and IR spectroscopy as well as MS. The novel ligand was then introduced onto a small AuNP 
surface through a place exchange reaction with methoxy terminated AuNPs. The novel NQMP 
functionalized AuNPs were then characterized by 1H NMR and IR spectroscopy as well as 
TGA and TEM. The amount of NQMP-modified ligand incorporated under the place exchange 
reaction conditions used within the ligand corona was also determined to be approximately 
20%. Finally, the photochemical properties of this novel template were investigated by UV-
Vis spectroscopy. The UV-Vis absorption spectrum revealed absorption maxima at 260 nm 
and 342 nm that are suitable for photochemical dehydration to the corresponding oNQM 
functionality by UV irradiation. Therefore, the next steps are to investigate the photochemistry 
of this novel system towards Diels-Alder cycloaddition and Michael addition substrates. In 
addition, the photochemical reversibility of this novel template can be explored. In the reaction 
between a thiol and oNQM, the resulting thioether linkage is stable under ambient conditions 
but can be cleaved by UV irradiation to regenerate the thiol. This interesting feature allows for 
the design of photochemically triggered delivery systems.  
 
2.4$Experimental$
$
Materials and Methods 
All reagents used were obtained from commercially available sources and used without 
further purification. 3,7-Dihydroxynapthoic acid, lithium aluminum hydride (LAH), 2,2-
dimethoxypropane, p-toluenesulfonic acid, tetra(ethylene glycol), p-toluenesulfonyl chloride, 
potassium thioacetate, imidazole, triphenylphosphines, potassium carbonate, Amberlyst 15 
hydrogen form wet and 4 Å molecular sieves were purchased from Sigma Aldrich. Iodine was 
purchased from Alfa Aesar. All common dry solvents were obtained from Caledon. Solvents 
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were dried using an Innovative Technologies solvent purification system, collected under 
vacuum, and stored under an argon atmosphere over 4 Å molecular sieves.  
1H NMR spectra were recorded on a Varian Inova 600 MHz spectrometer and 13C 
spectra were recorded on a Mercury 400 MHz spectrometer. 1H NMR spectra are reported as 
δ in units of parts per million (ppm) relative to residual chloroform proton (δ 7.27, s). 
Multiplicities are reported as follows: s (singlet), d (doublet), t (triplet), q (quartet), quin 
(quintuplet), dd (doublet of doublets), m (multiplet), and bs (broad signal). Coupling constants 
are reported as J values in Hertz (Hz). The number of protons (n) for a given resonance is 
indicated as nH, and is based on spectral integration values. 13C NMR spectra are reported as 
δ in units of parts per million (ppm) relative to CDCl3 (δ 77.0, t). Spectra were analyzed using 
ACD/SpecManager software v11.01. The spectra were baselined and integrated manually.  
Mass spectrometry data were recorded in positive-ion mode with a Bruker micOTOF 
II instrument using electrospray ionization or other ionization techniques as described. 
Transmission electron microscopy (TEM) images were recorded from a TEM Philips 
CM10 microscope. The TEM grids (Formvar carbon film on 400 mesh copper grids) were 
purchased from Electron Microscopy Sciences and prepared by dropcasting a drop of 
nanoparticles solution directly onto the grid surface. The drop was then carefully removed after 
30 s with a soft tissue. 
UV-Visible spectra were recorded using a Varian Cary 100 bio spectrometer and 1 mm 
plastic cuvettes. The nanoparticle samples were dissolved in distilled methanol. The 
background was automatically subtracted from each spectrum.  
FT-IR spectra were recorded using a PerkinElmer Spectrum Two FT-IR spectrometer 
using an attenuated total reflectance accessory. The background was subtracted from each 
spectrum.  
 
Synthesis of HO-NQMP 
 Lithium aluminum hydride (0.16 g, 4.2 mmol) was suspended in 
anhydrous THF (25 mL) under argon atmosphere then 3,7-
dihydroxynaphthoic acid (0.45 g, 2.1 mmol) dissolved in anhydrous THF (10 mL) was added 
dropwise with vigorous stirring. The reaction was stirred at room temperature for 3 h, quenched 
with 10% HCl(aq), filtered and extracted with Et2O. The organic layer was washed with brine 
(3 x 10 mL), dried with Na2SO4, filtered and concentrated under vacuum to give the product 
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as a light yellow solid (0.26 g, 67% yield).1H NMR (600 MHz, CD3OD): ! 7.56 (s, 1H), 7.48 
(d, J = 8.7 Hz, 1H), 7.03 (d, J = 2.3 Hz, 1H), 7.01 (s, 1H), 6.96 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 
4.77 (s, 2H). 13C{1H} NMR (75 MHz, CD3OD): ! 154.3, 152.7, 131.9, 131.1, 130.5, 128.3, 
126.1, 119.2, 110.3, 110.0, 61.7. EI-HRMS: Calculated for C11H10O3+ [M]+: 190.0630, found 
190.0632. 
 
Synthesis of HO-NQMP-pt 
2,2-Dimethoxypropane (1.5 mL, 12 mmol) and a catalytic amount of 
TsOH (100 mg) were added to a solution of HO-NQMP (0.65 g, 3.4 
mmol) dissolved in acetone (50 mL) with 4 Å molecular sieves. The reaction mixture was 
stirred overnight at room temperature. The solvent was removed under vacuum and the crude 
reaction mixture was purified by silica gel column chromatography using EtOAc/hexane (1:1) 
to give the product as a white solid (0.64 g, 82% yield). 1H NMR (600 MHz, CD3OD): ! 7.55 
(d, J = 8.7 Hz, 1H), 7.32 (s, 1H), 7.07 (s, 1H), 7.00-6.98 (m, 2H), 5.02 (s, 2H), 1.54 (s, 6H). 
13C{1H} NMR (75 MHz, CD3OD): ! 155.0, 149.1, 131.5, 130.2, 129.1, 123.1, 122.9, 119.8, 
112.8, 109.6, 100.9, 62.3, 25.4. IR (cm-1): 3369, 3002, 2926, 2856, 1615, 1523, 1392, 1355, 
1253, 1216, 1195, 1110, 1040, 896, 873, 821, 809, 751. EI-HRMS: Calculated for C14H14O3+ 
[M]+: 230.0943, found 230.0942. 
 
Synthesis of TsO-EG4-OH 
To a solution of tetraethylene glycol (100 mL, 0.579 mol) in 
THF (150 mL) was added NaOH (3.4 g dissolved in 10 mL H2O) and the reaction mixture was 
stirred vigorously for 15 min. At 0˚C, p-toluenesulfonyl chloride (10.5 g, 0.061 mol) was then 
slowly added to give a yellow solution. The reaction was left overnight at room temperature 
then H2O (150 mL) was added. The reaction mixture was then extracted with CH2Cl2 (3 x 80 
mL), dried over Na2SO4, filtered and concentrated under vacuum to give the mono-tosylated 
product as a yellow oil (16.57 g, 78% yield). 1H NMR (600 MHz, CDCl3): ! 7.81 (d, J = 12 
Hz, 2H), 7.35 (d, J = 12 Hz, 2H), 4.17 (t, J = 6 Hz, 2H), 3.73-3.60 (m, 14H), 2.45 (s, 3H). 
13C{1H} NMR (75 MHz, CDCl3): ! 144.7, 132.8, 129.7, 127.8, 72.4, 70.6, 70.5, 70.3, 70.2, 
69.2, 68.6, 21.5. IR (cm-1): 3440, 2871, 1598, 1452, 1351, 1175, 1096, 1012, 918, 816, 774, 
662, 553. CI-HRMS: Calculated for C15H24O7S+ [M+1]+: 348.1243, found 348.1242.  
 
HO O O O OTs
HO
O
O
!! !
41 
Synthesis of AcS-EG4-OH 
 Under argon atmosphere, to a solution of TsO-EG4-OH (7.37 
g, 21.1 mmol) dissolved in dry CH3CN (100 mL) was added KSAc (3.03 g, 26.5 mmol) to give 
a cloudy white solution. The reaction mixture was stirred overnight at 50˚C to give a yellow 
precipitate. The solution was filtered, concentrated under vacuum then purified by column 
chromatography using EtOAc to give the product as a light yellow oil (3.3091 g, 62 % yield). 
1H NMR (600 MHz, CDCl3): ! 3.74-3.73 (m, 2H), 3.68-3.60 (m, 12H), 3.10 (t, J = 6.4 Hz, 
2H), 2.34 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): ! 195.6, 72.5, 70.7, 70.5, 70.4, 70.3, 69.8, 
61.8, 30.6, 28.8. IR (cm-1): 3430, 2868, 1688, 1354, 1097, 952, 886, 625. CI-HRMS: 
Calculated for C10H20O5S+ [M+H]+: 253.1104, found 253.1108. 
 
Synthesis of AcS-EG4-I 
To a solution of AcS-EG4-OH (1.62 g, 6.42 mmol) dissolved in 
CH2Cl2 (60 mL) was sequentially added PPh3 (2.1694 g, 8.27 mmol), I2 (2.1102 g, 8.31 mmol) 
then imidazole (0.565 g, 8.30 mmol) to give a yellow-orange solution. The reaction mixture 
was left overnight to give a cloudy yellow solution. The reaction mixture was quenched with 
10% aqueous NaHSO3 (20 mL) to give a clear solution, extracted with CH2Cl2 (3 x 50 mL), 
dried with Na2SO4 and filtered. The resulting white solid was suspended in pentane (100 mL) 
and stirred for 45 minutes then filtered. The filtrate was evaporated and purified by silica gel 
column chromatography using EtOAc to give the iodinated product as a light yellow oil 
(2.0365 g, 88% yield). 1H NMR (600 MHz, CDCl3): ! 3.77 (t, J = 7.0 Hz, 2H), 3.67-3.60 (m, 
10H), 3.27 (t, J = 7.0 Hz, 2H), 3.11 (t, J = 6.4 Hz, 2H), 2.35 (s, 3H). 13C{1H} NMR (75 MHz, 
CDCl3): ! 195.5, 72.0, 70.7, 70.6, 70.3, 70.2, 69.8, 30.6, 28.8, 2.9. IR (cm-1): 2866, 1688, 1352, 
1100, 1034, 954, 625. CI-HRMS: Calculated for C10H19IO5S+ [M+H]+: 363.0121, found 
363.0116. 
 
Synthesis of AcS-EG4-NQMP-pt 
 To a solution of HO-NQMP-pt (0.274 g, 0.119 
mmol) dissolved in acetone (15 mL) was added 
K2CO3 (0.420 g, 0.30 mmol) followed by AcS-EG4-I (0.520 g, 0.143 mmol). The reaction 
mixture was refluxed overnight then the solvent was removed under reduced pressure and re-
dissolved in ethyl ether (100 mL), washed with brine (3 x 50 mL), dried with Na2SO4, filtered 
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and concentrated under vacuum. The crude mixture was purified by silica gel column 
chromatography using hexanes/EtOAc (1:1) to give the desired product as a light yellow oil 
(130 mg, 24% yield). 1H NMR (600 MHz, CDCl3): ! 7.59 (d, 8.8 Hz, 1H), 7.34 (s, 1H), 7.16 
(s, 1H), 7.12 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.03 (d, J = 2.3 Hz, 1H), 5.05 (s, 2H), 4.21 (t, J = 
5.3 Hz, 2H), 3.92 (t, J = 5.2 Hz, 2H), 3.77-3.75 (m, 2H), 3.71-3.69 (m, 2H), 3.67-3.65 (m, 4H), 
3.63-3.61 (m, 2H), 3.10-3.08 (m, 2H), 2.32 (s, 3H), 1.59 (s, 6H). 13C{1H} NMR (75 MHz, 
CDCl3): ! 195.5, 155.4, 148.1, 129.23, 129.18, 128.0, 122.1, 121.5, 119.3, 112.0, 106.2, 99.6, 
70.8, 70.7, 70.5, 70.3, 69.8, 69.7, 67.4, 61.2, 30.5, 28.8, 24.9. IR (cm-1): 2938, 2867, 1739, 
1690, 1614, 1512, 1349, 1257, 1201, 1116, 959, 886, 628. EI-HRMS: Calculated for 
C24H32O7S+ [M]+: 464.1869, found 464.1863. 
 
Synthesis of AcS-EG4-NQMP 
To a solution of AcS-EG4-NQMP-pt (125 mg, 
0.27 mmol) dissolved in CH3OH (5 mL) was 
added Amberlyst resin (200 mg) and stirred for 2 h. The resin was removed by filtration with 
a cotton plug then the solvent was removed under reduced pressure and the reaction mixture 
was purified by silica gel column chromatography using EtOAc/hexanes (3:1) to give the diol 
as a white solid (74 mg, 65% yield). 1H NMR (600 MHz, CDCl3): ! 7.55 (d, J = 8.8 Hz, 1H), 
7.35 (s, 1H), 7.35 (s, 1H), 7.16 (s, 1H), 7.10 (dd, J = 8.8 Hz, 2.3 Hz, 1H), 6.96 (d, J = 2.3 Hz, 
1H), 4.94 (s, 2H), 4.17-4.16 (m, 2H), 3.90-3.89 (m, 2H), 3.77-3.75 (m, 2H), 3.71-3.69 (m, 2H), 
3.66-3.64 (m, 2H), 3.62-3.60 (m, 2H), 3.57 (t, J = 6.4 Hz, 2H), 3.06 (t, J = 6.5 Hz, 2H), 2.87 
(s, 1H), 2.31 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): ! 195.8, 155.2, 152.3, 129.9, 129.0, 
127.8, 127.6, 125.9, 119.3, 111.0, 107.0, 70.8, 70.7, 70.5, 70.3, 69.8, 69.7, 67.4, 64.5, 30.5, 
28.8. EI-HRMS: Calculated for C21H28O7S+ [M]+: 424.1556, found 424.1544. 
 
Synthesis of HS-EG4-NQMP 
In the reaction flask, AcS-EG4-NQMP-pt (74 mg, 
0.17 mmol) was dissolved in CH3OH (10 mL) and 
purged with argon for 30 min. In separate flasks, 0.85 mL of 1 M NaOH in EtOH and 1.7 mL 
of 1 M HCl in H2O were also purged with argon for 30 min. The base was added to the reaction 
flask first and let stir for 1 h then the acid was added and stirred for 15 min. The thiol was then 
extracted using CH2Cl2 (3 x 10 mL). The resulting organic solution was then dried with 
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Na2SO4, filtered and concentrated under reduced pressure to give the thiol as a white solid (63 
mg, 97% yield). 1H NMR (600 MHz, CDCl3): ! 7.55 (d, J = 8.8 Hz, 1H), 7.37 (s, 1H), 7.17 (s, 
1H), 7.12 (dd, J = 8.8 Hz, 2.3 Hz, 1H), 6.93 (d, J = 2.3 Hz, 1H), 4.95 (s, 2H), 4.18-4.16 (m, 
2H), 3.91-3.89 (m, 2H), 3.77-3.75 (m, 2H), 3.72-3.70 (m, 2H), 3.69-3.67 (m, 2H), 3.64-3.60 
(m, 4H), 2.68 (dq, J = 8.2 Hz, J = 6.4 Hz, 2H), 1.58 (t, J = 8.2 Hz, 1H). 13C{1H} NMR (75 
MHz, CDCl3): ! 155.2, 152.3, 129.9, 129.1, 127.8, 127.7, 125.9, 119.4, 111.0, 107.0, 72.9, 
70.8, 70.7, 70.6, 70.2, 69.8, 67.4, 64.5, 24.2. IR (cm-1): 3448, 3214, 2867, 1611, 1394, 1245, 
1200, 1107, 990, 863. EI-HRMS: Calculated for C19H26O5S+ [M]+: 382.1450, found 382.1452. 
 
Synthesis of TrS-EG4-OH 
 To a solution of triphenylmethanethiol (4.02 g, 14.5 mmol) 
dissolved in a EtOH/benzene (1:1, 30 mL) was added NaOH (0.90 g, 23 mmol) dissolved in 
H2O (8 mL). TsO-EG4-OH (5.02 g, 14.4 mmol) was also dissolved in EtOH/benzene (1:1, 30 
mL) and added to the reaction mixture and let stir overnight. The reaction mixture was then 
washed with aqueous NaHCO3 (3 x 30 mL), brine (3 x 30 mL), dried with Na2SO4, filtered 
and concentrated under vacuum. The crude mixture was purified by silica gel column 
chromatography using hexane/EtOAc (1:1) to give the product as a clear and colorless oil (5.09 
g, 77% yield). 1H NMR (600 MHz, CDCl3): ! 7.43 (d, J = 12 Hz, 6H), 7.29 (t, J = 12 Hz, 6H), 
7.22 (t, J = 12 Hz, 3H), 3.73-3.70 (t, J = 6 Hz, 2H), 3.66-3.58 (m, 8H), 3.48-3.45 (m, 2H), 3.31 
(t, J = 6Hz, 2H), 2.45 (t, J = 6 Hz, 2H). 13C{1H} NMR (75 MHz, CDCl3): ! 144.8, 129.6, 127.9, 
126.6, 72.4, 70.6, 70.4, 70.3, 70.1, 69.6, 66.6, 61.8, 31.6. IR (cm-1): 3453, 3065, 2922, 2866, 
1488, 1444, 1100, 743, 700. ESI-HRMS: Calculated for C27H32O4S+ [M+Na]+: 475.1914, 
found 475.1914. 
 
Synthesis of TrS-EG4-I 
 To a solution of TrS-EG4-OH (0.48 g, 1.1 mmol) dissolved in 
CH2Cl2 (20 mL) was sequentially added PPh3 (0.38 g, 1.4 mmol), I2 (0.360 g, 1.4 mmol) then 
imidazole (0.116 g, 1.7 mmol) to give a yellow-orange solution. The reaction mixture was left 
overnight to give a cloudy white solution. The reaction mixture was quenched with 10% 
aqueous NaHSO3 (20 mL) to give a clear solution, extracted with CH2Cl2 (3 x 50 mL), dried 
with Na2SO4 and filtered. The resulting white solid was suspended in pentane (100 mL) and 
stirred for 45 minutes then filtered. The volatile components of the filtrate were evaporated 
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then the crude mixture was purified by silica gel column chromatography using hexane/EtOAc 
(2:1) to give the iodinated product as a light yellow oil (452 mg, 75% yield). 1H NMR (600 
MHz, CDCl3): ! 7.44 (d, J = 12 Hz, 6H), 7.29 (t, J = 12 Hz, 6H), 7.22 (t, J = 12 Hz, 3H), 3.74 
(t, J = 6 Hz, 2H), 3.64 (m, 4H), 3.61-3.58 (m, 2H), 3.49-3.46 (m, 2H), 3.32 (t, J = 6 Hz, 2H), 
3.24 (t, J = 6 Hz, 2H), 2.46 (t, J = 6 Hz, 2H). 13C{1H} NMR (75 MHz, CDCl3): ! 144.7, 129.5, 
127.8, 126.5, 71.9, 70.5, 70.4, 70.1, 70.0, 69.5, 66.5, 31.6, 3.00. IR (cm-1): 3054, 2922, 2864, 
1597, 1488, 1443, 1106, 1034, 743, 700. ESI-HRMS: Calculated for C27H31IO3S + [M+Na]+: 
585.0931, found 585.0941. 
 
Synthesis of TrS-EG4-NQMP-pt 
 To a solution of HO-NQMP-pt (0.101 g, 0.44 
mmol) in acetone (15 mL) was added K2CO3 
(0.138 g, 1.1 mmol) followed by TrS-EG4-I (0.273 g, 0.49 mmol). The reaction mixture was 
refluxed overnight then the solvent was removed under reduced pressure and re-dissolved in 
ethyl ether (100 mL), washed with brine (3 x 50 mL), dried with Na2SO4, filtered and 
concentrated under vacuum. The crude mixture was purified by silica gel column 
chromatography using hexanes/EtOAc (3:2) to give the desired product as a light yellow oil 
(130 mg, 44% yield). 1H NMR (600 MHz, CDCl3): ! 7.59 (d, J = 8.7 Hz, 1H), 7.44 (d, J = 7.6 
Hz, 6H), 7.33 (s, 1H), 7.28 (t, J = 7.6 Hz, 6H), 7.21 (t, J = 7.6 Hz, 3H), 7.18 (s, 1H), 7.12 (dd, 
J = 8.7 Hz, 2.3 Hz, 1H), 7.02 (d, J = 2.3 Hz), 5.02 (s, 2H), 4.21 (t, J = 7.0 Hz, 2H), 3.90 (t, J = 
7.0 Hz, 2H), 3.75-3.74 (m, 2H), 3.69-3.67 (m, 2H), 3.61-3.60 (m, 2H), 3.48-3.47 (m, 2H), 3.33 
(t, J = 7.0 Hz, 2H), 2.46 (t, J = 7.0 Hz, 2H), 1.61 (s, 6H). 13C{1H} NMR (75 MHz, CDCl3): 
!155.4, 148.1, 144.8, 129.6, 129.3, 129.2, 128.0, 127.9, 126.6, 122.1, 121.5, 119.3, 112.0, 
106.3, 99.6, 70.8, 70.7, 70.2, 69.8, 69.6, 67.4, 66.6, 61.2, 31.7, 25.0. IR (cm-1): 3057, 1991, 
2922, 2965, 1613, 1512, 1488, 1444, 1372, 1348, 1246, 1257, 1136, 1116, 959, 885, 744, 702. 
ESI-HRMS: Calculated for C41H44O6S + [M+Na]+: 687.2756, found 687.2776. 
 
Synthesis of TrS-EG4-NQMP 
 To a solution of TrS-EG4-NQMP-pt (0.318 g, 
0.48 mmol) dissolved in CH3OH (5 mL) was 
added Amberlyst resin (600 mg) and stirred for 2 h. The resin was removed by filtration with 
a cotton plug then the solvent was removed under reduced pressure and the reaction mixture 
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was purified by silica gel column chromatography using EtOAc/hexanes (2:1) to give the diol 
as a white solid (0.23 g, 77% yield). 1H NMR (600 MHz, CDCl3): ! 7.53 (d, J = 8.7 Hz, 1H), 
7.41 (d, J = 7.6 Hz, 6H), 7.35 (m, 2H), 7.27 (t, J = 7.6 Hz, 6H), 7.20 (t, J = 7.6 Hz, 3H), 7.16 
(s, 1H), 7.09 (dd, J = 8.7 Hz, J = 2.3 Hz, 1H), 6.95 (d, J = 2.4 Hz, 1H), 4.93 (s, 2H), 4.15-4.13 
(m, 2H), 3.88-3.97 (m, 2H), 3.74-3.72 (m, 2H), 3.67-3.66 (m, 2H), 3.59-3.58 (m, 2H), 3.46-
3.44 (m, 2H), 3.30 (t, J = 7.0 Hz, 2H), 2.43 (t, J = 7.0 Hz, 2H). 13C{1H} NMR (75 MHz, 
CDCl3): ! 155.2, 152.3, 144.8, 129.8, 129.6, 129.0, 127.9, 127.6, 126.6, 125.9, 119.3, 110.9, 
107.0, 70.8, 70.7, 70.5, 70.1, 69.8, 69.6, 67.4, 66.6, 64.4, 31.6. ESI-HRMS: Calculated for 
C38H40O6S + [M+Na]+: 647.2438, found 647.2434. 
 
Synthesis of AuNP-EG3-OMe 
AuNP-EG3-OMe were synthesized according to our previously established 
procedure.[8] Briefly, HAuCl4·3H2O (1.5 g, 3.7 mmol, 1.0 eq.) was dissolved 
in a mixture of distilled CH3OH (500 mL) and glacial acetic acid (86 mL) to 
give a yellow solution then HS-EG3-OMe (2.0 g, 11 mmol, 3.0 eq.). The 
solution darkened slightly in color and was stirred vigorously for two hours 
at room temperature until the solution color slightly faded. A solution of 
NaBH4 (1.4 g, 38 mmol, 10.0 eq.) dissolved in Millipore quality H2O (98 mL) was added 
dropwise to the reaction mixture under vigorous stirring. The mixture turned dark brown 
immediately. The resulting solution was stirred overnight at room temperature then the solution 
was concentrated under vacuum and redissolved with brine (200 mL). The AuNP-EG3-OMe 
nanoparticles were extracted with toluene (6 x 50 mL) while adding sodium chloride to the 
aqueous phase after each extraction to maintain the saturation. The aqueous phase was 
eventually colorless. The combined organic phases were then concentrated in vacuo. 
Evaporation of the solvent left a thin film of nanoparticles which was then rinsed with hexanes 
to remove the excess free thiol. The crude Me-EG3-AuNPs were dissolved in nanopure H2O 
and further purified by overnight dialysis. The solvent was then removed under reduced 
pressure and thoroughly dried in vacuo to give AuNP-EG3-OMe. 1H NMR (600 MHz, CDCl3) 
δ 3.58, 3.66 (-CH2-), 3.36 (-OCH3). 
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Synthesis of AuNP-EG4-NQMP 
To a solution of AuNP-EG3-OMe (42 mg) in CH2Cl2 (4 mL) was added a 
solution of HS-EG4-NQMP (19 mg, 0.18 mmol) in CH2Cl2 (1 mL) under 
an argon atmosphere while stirring vigorously. After 2 h of stirring, the 
solution was concentrated under reduced pressure to give a thin film of 
nanoparticles. The residue was washed with Et2O (20 mL) to remove 
excess thiol. The nanoparticles were then re-dissolved in 1:1 
CH2Cl2/CH3OH (20 mL) and the solvent was removed under reduced 
pressure to reform the thin film. This washing procedure was performed 
five more times (six total) and the resulting AuNP-EG4-NQMP were dried 
in vacuo. 1H NMR (600 MHz, CDCl3): δ 7.92, 7.55, 7.13, 4.91, 4.17, 3.62, 3.36.  
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CHAPTER(3(
(
3.1$ Introduction$
 
In recent decades, AuNPs have attracted significant attention because of unique size-
dependent physical, chemical and biological properties. In particular, large AuNPs display a 
surface plasmon resonance (SPR) phenomenon resulting in sharp absorption in the visible[1] or 
NIR[2] range. The strongly absorbed light is also converted to heat so larger AuNPs have been 
utilized in thermal ablation therapy.[3] However, the stabilization and functionalization of large 
AuNPs that are stable and water-soluble is challenging so the ability to further exploit the SPR 
for in vivo applications such as imaging or PTT is limited. In the literature, PEG is most 
commonly used to stabilize large citrate-stabilized AuNPs through a ligand exchange reaction 
but it presents a dilemma as described in Chapter 1. High molecular weight PEG provides 
excellent stability but poor conjugation ability. On the other hand, low molecular weight PEG 
enables high conjugation ability but provides minimal stability resulting in irreversible 
aggregation. In addition, the functionalization of large AuNPs is mainly limited to 
carbodiimide-mediated conjugation to carboxylic acid terminated PEG AuNPs (Figure 3.1). It 
is also reported that PEG forms a tight monolayer around the large AuNP core that inhibits 
place-exchange reactions with other thiols.[4] Therefore, the scope of large AuNP 
functionalization is very limited as a result of stability concerns and poor ability to perform 
interfacial chemistry. As described in Chapter 1, the Workentin AuNP toolbox contains a wide 
variety of templates for the functionalization of small (1-5 nm) water-soluble AuNPs via click 
and bioorthogonal interfacial chemistry. The goal of the work presented in Chapter 3 was to 
develop a method prepare larger AuNPs (> 10 nm) that are stable and allow for the introduction 
of functional groups from the click and bioorthogonal toolbox.  
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Scheme 3.1: Example of carbodiimide-mediated protein conjugation to carboxylic acid 
terminated PEG AuNPs.  
 
Our design was to synthesize larger AuNPs by the Turkevich method[5] to yield AuNPs 
ranging in size from 15-40 nm then introduce functionality through a place exchange reaction 
with citrate-stabilized AuNPs using an appropriately designed ligand. Figure 3.1 is presented 
again from Chapter 1 to help describe the synthetic strategy. Through a convergent approach, 
hydrophilic ligands of discrete size were designed that stabilize the gold core through thiol 
binding at the head but can also undergo interfacial chemistry at the tail to impart functionality 
(Figure 3.1). An –OCH3 terminus was used as a model to impart solubility in both organic 
media and water to the system. In addition, the ligand contains an ethylene glycol based 
repeating unit that is conjugated to the head and tail through amide bonds. It is predicted that 
as a result of the amide conjugation, these ligands will form a network of hydrogen bonding 
shells around the gold core for increased stabilization and hydrophilicity[6] (Figure 3.2). Also, 
the ligand length may be systematically adapted by increasing the number of repeating units 
to account for increased AuNP core size. All synthetic intermediates were characterized by 1H 
NMR, 13C NMR and IR spectroscopy as well as MS. The AuNPs synthesized were also 
characterized by UV-Vis spectroscopy and TEM. 
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Figure 3.1: Retro-synthesis of the model ligand (n = 1) and highlighted features (Reprinted 
from Chapter 1) 
 
The novel ligands were then used to stabilize the citrate-stabilized large AuNPs through 
a place exchange reaction. To the best of our knowledge, this is a demonstration of the smallest 
molecular weight ligand used to successfully stabilize larger AuNPs (>10 nm). This novel large 
AuNP template was then characterized by the standard techniques used for large NP 
characterization including UV-Vis spectroscopy and TEM. Once stabilized, the synthetic 
approach may be easily modified in order to develop versatile AuNP templates with click and 
bioorthogonal functional groups from the Workentin AuNP toolbox. Through the synthesis of 
a modified Fragment C, it is possible to introduce a variety of click and bioorthogonal 
functional groups to the large AuNP surface through a place exchange reaction with the 
template presented in this chapter. Figure 3.2 is presented again from Chapter 1 to showcase 
the overall design including the hydrogen bonding stabilization pattern as well as the 
introduction of click and bioorthogonal functional groups for the development of novel large 
AuNP templates.  
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Figure 3.2: Design of novel ligand with hydrogen bonding shells. The tail may be replaced 
with bioorthogonal functional groups (Reprinted from Chapter 1). 
 
3.2$ Results$and$Discussion$
(
3.2.1$Synthesis$of$Fragment$A$
 
In order to synthesize the ligands described in Scheme 3.1, a 
convergent approach was used by assembling three individual 
fragments together. Fragment A was synthesized according to a 
procedure reported in the literature[7]. It was selected as a result of its facile synthesis and 
bifunctional nature. On one end, the trityl-protected thiol is very resilient to a variety of 
reaction conditions and can be readily removed upon treatment with acid. At the other end, the 
NHS-activated carboxylic acid provides an excellent leaving group for subsequent amide 
conjugation (Scheme 3.2).  
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Scheme 3.2: Synthesis for thiol protection TrS-(CH2)2-COOH and activated ester TrS-(CH2)2-
NHS. 
 
Fragment A was characterized by mass spectrometry (MS) as well as 1H and 13C NMR 
spectroscopy. Through a nucleophilic substitution reaction, the thiol in compound 3.1 was 
protected as evidenced by three characteristic signals in the 1H NMR spectra of 3.2. A doublet 
at 7.42 ppm, triplet at 7.29 ppm and another triplet at 7.22 ppm indicate the benzylic hydrogens 
and successful incorporation of the protecting group. Subsequently, activation of the 
carboxylic acid with NHS gave rise to a strong singlet at 2.81 ppm with an integration of 4H. 
In the 13C NMR spectrum of compound 3.3 there was also an appearance of a signal relating 
to the addition of the second chemically equivalent carbonyl groups in NHS.  
 
3.2.2$Synthesis$of$Fragment$B$
 
In Fragment B, tetraethylene glycol (compound 3.4) was 
selected as the backbone of the repeating unit to impart both 
organic and water solubility to the final ligand. In this 
fashion, it is possible to perform interfacial chemistry on the AuNP in organic media as well 
as biological solutions. As described in Scheme 3.3, commercially available tetraethylene 
glycol was tosylated to give the mono-tosylated compound 3.5. The tosylate was selected as it 
is a good leaving group and also acts as a hydroxyl protecting group in subsequent reactions. 
Next, the primary alcohol was oxidized to the corresponding carboxylic acid using a catalytic 
amount of pyridinium chlorochromate (PCC). The intermediate 3.6 was extracted to remove 
excess acid and carried through to the next step without further purification. An esterification 
reaction was then performed by simply dissolving 3.6 in an acidic solution of methanol and 
refluxing for two hours. The intermediate 3.7 was characterized with 1H NMR spectroscopy 
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by the appearance of a strong singlet at 3.76 ppm with an integration of 3H consistent with the 
formation of a methyl ester. Finally, sodium azide was reacted with 6 through a nucleophilic 
substitution reaction to afford the azido compound 3.8. The 1H NMR spectrum revealed a 
triplet at 3.39 ppm relating to the protons alpha to the azide functionality. Additionally, there 
was a disappearance of the aromatic signals in both the 1H and 13C NMR spectra resulting from 
substitution of the tosyl group. Compound 3.8 was not reduced to the corresponding amine 
because of difficulties encountered when attempting to isolate the product. It was believed that 
the methyl ester may have been susceptible to nucleophilic attack from amines so Fragment B 
was carried through as the azide compound 3.8. Instead I developed a one-pot reaction where 
the amine was formed in situ in Scheme 3.6. I later realized that the Pd/C catalyst was actually 
no longer active but the one-pot protocol had already yielded good results. The infrared (IR) 
spectrum of compound 3.8 included intense signals at 2107 cm-1 and 1739 cm-1 characteristic 
of azide and carbonyl stretching frequencies, respectively.  
 
Scheme 3.3: Synthesis of Fragment B. 
 
3.2.3$Synthesis$of$Fragment$C$
 
Fragment C was also synthesized according to a modified procedure 
reported in the literature.[8] As described in Scheme 3.4, the final 
fragment includes an amino functionality for amide conjugation. It 
also includes a terminal methoxy group (compound 3.9) in order to provide the desired 
solubility in both organic and aqueous media to the final AuNP as previously demonstrated by 
our group. This group may also be easily replaced by biorthogonal functional groups that can 
be installed in future investigations. Briefly, triethylene glycol monomethyl ether was tosylated 
prior to reaction with sodium azide to install the azido functionality. Next, reduction of the 
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azide was catalyzed by palladium on carbon to give the final amino functionalized fragment in 
very high yield.  
 
Scheme 3.4: Synthesis of Fragment C. 
 
The characterization of the compounds described in Scheme 3.4 was completed by 1H 
and 13C NMR spectroscopy as well as MS. In the 1H NMR spectrum of compound 3.10, an 
appearance of two doublets at 7.70 and 7.26 ppm with a total integration of 4H confirmed the 
introduction of the tosyl group. The corresponding azido compound 3.11 was then 
characterized by the disappearance of the previously mentioned signals. Finally, upon 
catalyzed reduction of the azide to give compound 3.12, in the 1H NMR spectrum there was 
an appearance of a broad singlet at 2.16 ppm with an integration of 2 corresponding to the 
amine protons.  
 
3.2.4$Synthesis$of$Required$Ligands$
 
In order to synthesize the desired ligands, the individual fragments A, B and C were 
coupled together through the formation of amide bonds where: Fragment A contains the thiol 
for binding to the gold core, Fragment B is the repeating unit represented by n, and Fragment 
C contains a terminal methoxy group as a model for bioorthogonal functionalities. It is 
predicted that the amide bonds will provide additional stabilization to the large AuNP through 
lateral hydrogen bonding in hydrogen bonding shells. In addition, all three fragments were 
synthesized in good yield on a gram scale.  
The desired ligand was first synthesized without Fragment B, or the repeating unit 
(Scheme 3.5). Consequently, the ligand only contains one hydrogen bonding shell. Briefly, 
Fragment C (compound 3.12) was reacted with Fragment B (compound 3.3) in high yield to 
give the amide coupled intermediate 3.13. The thiol was then deprotected by treatment with 
trifluoroacetic acid (TFA) in the presence of triisopropylsilyl ether (TIPS) to give the ligand 
with n = 0.  
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Scheme 3.5: Synthesis of ligand without repeating unit (n = 0) 
 
The ligand 3.14 was fully characterized by 1H and 13C NMR spectroscopy as well as 
MS. Upon coupling through amide bond formation, in the 1H NMR spectrum there was an 
appearance of a broad singlet at 6.45 ppm indicative of successful coupling. As well, removal 
of the trityl group resulted in the disappearance of the corresponding aromatic protons. 
Additionally, a triplet appeared at 1.63 ppm highlighting the reformation of the SH bond.  
The desired ligand was then synthesized with one repeating unit contained within the 
structure such that two hydrogen bonding shells would provide increased stabilization (Scheme 
3.6). In a one pot reaction, Fragment B was formed in situ by reduction of compound 3.8 
catalyzed by Pd/C and coupling with Fragment A (compound 3.3) through amide bond 
formation was also achieved. The intermediate 3.15 was isolated in high yield demonstrating 
the feasibility of the one pot reaction. Next, the methyl ester was hydrolyzed to give the 
corresponding carboxylic acid intermediate 3.16. Through an HBTU mediated coupling, the 
acid intermediate was coupled with Fragment C to give compound 3.17 with two amide bonds 
contained within the molecular structure. Initial efforts to activate the carboxylic acid with 
NHS prior to coupling were not successful. Finally, the trityl protecting group could be cleaved 
by treatment with TFA in good yield to give ligand 3.18.  
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Scheme 3.6: Synthesis of ligand with one repeating unit (n = 1). 
 
The intermediates described in Scheme 6 were characterized by 1H and 13C NMR 
spectroscopy as well MS. After the one-pot reaction, successful coupling to give compound 
3.15 was noted by the appearance of a broad singlet at 5.93 ppm in the 1H NMR spectrum 
indicating the presence of an amide proton. As well, ethylene protons in Fragment A shifted 
upfield. In the 13C NMR spectrum, appearance of a carbonyl signal confirmed successful 
coupling. Next, the hydrolyzed product 3.16 was characterized by the disappearance of a 
singlet integrating to 3H in the 1H NMR spectrum at 3.70 ppm. Interestingly, the ethylene 
glycol protons were also more well resolved following hydrolysis. The next HBTU mediated 
amide coupling step could be tracked very well by 1H & 13C NMR spectroscopy. In the 1H 
NMR spectrum of 3.17, integration of ethylene glycol signals corresponded to the expected 
29H. The appearance of a second amide bond could also be observed in the 1H NMR spectrum 
but it was difficult to resolve from the aromatic protons. The 13C NMR spectrum also revealed 
the formation of a second amide bond through a carbonyl signal at 170.1 ppm. However, upon 
removal of the trityl protecting group, both amide protons were beautifully well-resolved in 
the 1H NMR spectrum of 3.18 (Figure 3.3). The SH signal also appeared as a triplet at 1.62 
ppm. The methylene protons adjacent to the sulfhydryl functional group appeared as a false 
quartet. It should be a doublet of triplets but the difference in magnitude of the coupling 
constants was too small to clearly resolve the complex splitting pattern. In addition, as a result 
of the gram scale synthesis of each fragment and good yield in the ligand synthesis, the ability 
to scale the synthesis and develop large quantities of the ligands is straightforward.  
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Figure 3.3: 1H NMR spectrum of HS-EG4-EG3-OMe in CDCl3. * denotes residual protonated 
solvent signals or solvent impurities. 
 
3.2.5$Synthesis$and$UVEVis$Spectra$of$CitrateEStabilized$AuNPs$
 
AuNPs were synthesized by reducing gold chloride using the standard sodium citrate 
method. Briefly, to a solution of H2O (10 mL) with a stir bar was added 0.2 mL of HAuCl4•H2O 
stock solution (1% w/v in H2O) diluted to 10 mL H2O to give a 0.01% Au solution. The solution 
was brought to boiling with vigorous stirring prior to adding the desired volume of sodium 
citrate stock solution (1% w/v). After the solution turned red in color, boiling was continued 
for 5 minutes then the solution was cooled to room temperature. By varying the sodium citrate 
to gold ratio, it was possible to control the size of the AuNPs. UV−vis absorption spectra were 
acquired to determine the characteristic plasmon resonance absorption peak of the AuNPs 
(Figure 3.4) and identify the approximate size. The results are summarized in Table 3.1. The 
plasmon bands red-shifted and broadened with increase in size, in good agreement with 
previously reported results.[9]  
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Table 3.1: Synthesis of large AuNPs by sodium citrate reduction. 
HAuCl4•H2O (µL) 100 100 100 100 
Sodium citrate (µL) 100 125 150 200 
!max (nm) 529 526 524 519 
Size (nm) 40 30 20 15 
 
 
Figure 3.4: UV-Vis spectra in nanopure H2O of citrate-stabilized AuNP synthesized by the 
Turkevich method. 
Interestingly, the smaller AuNPs (15-20 nm) could be centrifuged and redispersed in 
water without detectable aggregation. However, centrifugation and redispersion in water of the 
larger citrate-stabilized AuNPs (30-40 nm) resulted in irreversible aggregation as demonstrated 
by drastic discoloration of the solution from red to blue and broadening of the plasmon in the 
UV−vis absorption spectra. In order to prepare concentrated solutions of the larger AuNPs, it 
has been demonstrated that Tween 20 surfactant is able to prevent aggregation upon 
centrifugation and redispersion. Tween surfactants are able to weakly physisorb on the surface 
of AuNPs with diameters from 20 to 175 nm to provide steric stabilization and prevent 
aggregation.[9] Importantly, the surfactant layer can still be displaced and undergo place 
exchange reactions with thiols such as PEG-SH. Schollbach et al., also investigated the ability 
of OEG thiols to stabilize AuNPs.[10] It is reported that short chain OEG with 2-4 EG units can 
only stabilize AuNPs less than 3 nm in diameter. However long chain HSC11EG6 ligands were 
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able to stabilize AuNPs larger than 10 nm (Figure 3.5). So to investigate the stabilizing 
efficiency of the ligands 3.14 and 3.18, 20 nm citrate-stabilized AuNPs were selected.  
 
Figure 3.5: Cartoon representation of a large AuNP stabilized by a monolayer of OEG ligands. 
The hydrophobic C11-chain provides stability while the hydrophilic EG unit ensures solubility 
in water (-OH) and both water and organic solvent (-OCH3).  
For the 20 nm AuNPs, the approximate size was first calculated from the UV-Vis 
spectrum using the ratio of the absorbance at the surface plasmon resonance peak (Aspr) to the 
absorbance at 450 nm (A450) based on a linear fit between theoretical and experimental data:[11]  
! = exp& '( )*+,)-./ − '1  '( is the inverse of the slope (m) of the linear fit between theoretical and experimental data 
and '1 = 234  where '/ is the intercept. For AuNPs less than 35 nm, the Aspr is increasingly 
damped relative to absorbance at other wavelengths. As a result, it is necessary to use a ratio 
of absorbances to determine the AuNP size. Using wavelengths higher than the plasmon was 
not suitable because of small amounts of aggregates that would absorb at these higher 
wavelengths. Instead, good agreement was found using the absorbance ratio of wavelengths 
below 600 nm due to less interference. In the end, strong agreement was found between 
theoretical and experimental data using the absorbance ratio of the surface plasmon resonance 
peak and the absorbance at 450 nm. Thankfully, the authors compiled a table of the numerical 
data from Equation 1 enabling the size determination of AuNPs without the need to perform 
any calculations. The average size (20 ± 1 nm) and spherical shape was then confirmed by 
TEM (Figure 3.6). These results are in excellent agreement with the calculated results 
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highlighting the dynamic power of the surface plasmon in the determination of AuNP size.   
 
 
 
 
 
 
 
 
 
Figure 3.6:  TEM image of 20 nm citrate-stabilized AuNPs (average size = 20 ± 1 nm). The 
scale bar is indicated. 
3.2.6$Stabilization$of$20$nm$CitrateEStabilized$AuNPs$
Initial attempts at stabilizing the 20 nm AuNP core using 
ligand 3.14 proved unsuccessful as demonstrated by drastic 
fading in the color of the solution from red to blue (Figure 
3.7) and broadening of the plasmon in the UV−vis absorption 
spectra. This is an indication of irreversible aggregation and that 3.14 was not able to provide 
sufficient stabilization. This result also highlighted the challenge of stabilizing AuNPs larger 
than 10 nm as methoxy terminated triethylene glycol ligands are routinely used to stabilize 
small AuNPs.  
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Figure 3.7: Example of visual discoloration of AuNP solution due to aggregation (left vs. 
right).  
However, the successful stabilization of the 
20 nm AuNPs was accomplished with ligand 
3.18 and characterized with UV-Vis 
absorption spectra as well as TEM images. 
First, the concentration of AuNPs dissolved in 1.0 mL of water was determined using the 
methodology developed by Haiss et al. In addition to being able to determine the size of AuNPs 
with UV-Vis spectra, it is also possible to determine the concentration of the AuNP solution. 
The authors calculated the molar extinction coefficients of AuNPs with diameters ranging from 
2 to 100 nm based on the absorbance at 450 nm.[11] Using the Beer-Lambert equation it is 
possible to calculate the AuNP concentration: )-./ = 5-./67 
In the above equation, )-./ is the absorbance and 5-./ is the molar extinction coefficient at 
450 nm. With a standard path length (6) of 1 cm, the concentration (7) can be determined 
according to: 
7 = )-./5-./  
Next, using a simple calculation considering the total AuNP surface area and the cross sectional 
area of the thiol molecule it is possible to determine the idealized maximum coverage, or 
number of ligands required to encapsulate the AuNP surface. For example, in an ideal 
monolayer of long chain alkanethiolates on a Au surface, a thiolate possesses a footprint[12] of 
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0.214& ?@1AℎCDEFAG 
Thus, a 20 nm AuNP with a surface area of  
H) = 4IJ1 = 1256 M4NOPQR  
requires 
1256 ?@1)STU× AℎCDEFAG0.214&?@1 = 5869 AℎCDEFAGY)STU  
in order to provide maximum coverage. The AuNP concentration was found to be 2.65&×&10Z(/&[ in 1.0 mL of water then 32 µL of a 2.65&×&10Z(/&[ solution of 3.18 was 
added and vigorous shaking was applied. It is important to note that relative to the idealized 
maximum coverage a 10-fold excess of ligands was used. Then 1.5 h after place exchange, the 
AuNPs were centrifuged four times (30 min at 6000 rpm), including replacement of the 
supernatant with water to remove excess ligand. After place exchange, the AuNPs could be 
centrifuged and redispersed in water without detectable aggregation. There was no 
discoloration of the solution observed unlike the previous attempt using the smaller ligand. 
Successful place exchange could be confirmed through UV-vis absorption spectroscopy 
(Figure 3.8). As the plasmon is influenced by the surface chemistry, replacement of the citrate 
layer results in a shift of the wavelength of maximum absorption by a few nanometers. This 
expected shift was observed. Additionally, a lower absorbance was observed after place 
exchange due to some AuNPs being removed with the supernatant during purification. 
However, the plasmon was not significantly broadened indicating little to no aggregation after 
place exchange.  
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Figure 3.8: Colloidal stability of HS-EG4-EG3-OMe stabilized 20 nm AuNPs characterized by 
UV−vis measurement in nanopure H2O. The lower absorbance is a result of material loss 
during purification. The normalized absorbance spectra shown in the inset demonstrates the 
shift of the surface plasmon resonance band (Δλ = 5 nm) after place exchange. 
             TEM images were also collected after place exchange (Figure 3.9). The average size 
was found to be 21 ± 2 nm in good agreement with the citrate-stabilized AuNP precursor. 
Therefore, the shift in the surface plasmon observed in Figure 3.8 can be attributed to 
successful place exchange as there was no significant change in size or shape following 
displacement of the citrate ions. 
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Figure 3.9: TEM image of HS-EG4-EG3-OMe stabilized AuNPs. The scale bar is indicated. 
 
3.3$$$Conclusion$
 
In the literature, PEG-SH has displayed a poor balance between colloidal stability and 
functionalization so the ability to exploit the optical properties of large AuNPs remains elusive. 
In addition, common spectroscopic techniques such as NMR spectroscopy are not applicable 
for characterization. These polymer-AuNP systems are also unable to undergo place exchange 
reactions so conjugation is typically achieved through carbodiimide chemistry limiting the 
scope of interfacial chemistry. The ligand designed in this project addresses these issues as a 
result of its discrete size and ability to form hydrogen bonding shells. The ligand was 
successfully synthesized in high yield and incorporated onto the surface of 20 nm AuNPs. It is 
the lowest molecular weight thiolated ethylene glycol based ligand to be shown to stabilize 
large AuNPs. Successful place exchange was characterized by UV-Vis spectroscopy and the 
size was confirmed by TEM. The synthetic strategy may now be modified to incorporate click 
and bioorthogonal functional groups from the Workentin AuNP toolbox. The synthesis may 
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be repeated on a multi gram scale and with a modified Fragment C that contains one of the 
versatile functional groups previously described. In this manner it will be possible to develop 
novel click and biorthogonal large AuNP templates on a large scale to investigate their 
interfacial chemistry for in vivo applications. In conclusion, the work presented in this chapter 
are the first steps towards transposing the vast knowledge in our group obtained from designing 
small AuNP templates onto larger AuNP systems. Preliminary results indicate that stabilization 
was successful but characterization by 1H NMR spectroscopy would provide further 
confirmation as well as the ability to follow the interfacial chemistry. This will enable us to 
take advantage of the SPR and its interesting absorption, scattering and photothermal 
properties through more versatile functionalization routes using click and bioorthogonal 
interfacial chemistry.  
 
3.4$ Experimental$
Materials and Methods 
All reagents used were obtained from commercially available sources and used without 
further purification. Tritylchloride, N-hydroxysuccinimide (NHS), dicyclohexylcarbodiimide 
(DCC), tetra(ethylene glycol), p-toluenesulfonyl chloride, pallidum on carbon (Pd/C), sodium 
azide and pyridinium chlorochromate (PCC) were purchased from Sigma Aldrich. 4-
Dimethylaminopyridine (DMAP) was purchased from Alfa Aesar. All common dry solvents 
were obtained from Caledon. Solvents were dried using an Innovative Technologies solvent 
purification system, collected under vacuum, and stored under an argon atmosphere over 4 Å 
molecular sieves.  
1H NMR spectra were recorded on a Varian Inova 600 MHz spectrometer and 13C 
spectra were recorded on a Mercury 400 MHz spectrometer. 1H NMR spectra are reported as 
δ in units of parts per million (ppm) relative to residual chloroform proton (δ 7.27, s). 
Multiplicities are reported as follows: s (singlet), d (doublet), t (triplet), q (quartet), quin 
(quintuplet), dd (doublet of doublets), m (multiplet), and bs (broad signal). Coupling constants 
are reported as J values in Hertz (Hz). The number of protons (n) for a given resonance is 
indicated as nH, and is based on spectral integration values. 13C NMR spectra are reported as 
δ in units of parts per million (ppm) relative to CDCl3 (δ 77.0, t). Spectra were analyzed using 
ACD/SpecManager software v11.01. The spectra were baselined and integrated manually.  
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Mass spectrometry data were recorded in positive-ion mode with a Bruker micOTOF 
II instrument using electrospray ionization or other ionization techniques as described. 
Transmission electron microscopy (TEM) images were recorded from a TEM Philips 
CM10 microscope. The TEM grids (Formvar carbon film on 400 mesh copper grids) were 
purchased from Electron Microscopy Sciences and prepared by dropcasting a drop of 
nanoparticles solution directly onto the grid surface. The drop was then carefully removed after 
30 seconds with a soft tissue. 
UV-Visible spectra were recorded using a Varian Cary 100 bio spectrometer and 1 mm 
plastic cuvettes. The nanoparticle samples were dissolved in Millipore quality H2O. The 
background was automatically subtracted from each spectrum.  
FT-IR spectra were recorded using a PerkinElmer Spectrum Two FT-IR spectrometer 
using an attenuated total reflectance accessory. The background was subtracted from each 
spectrum.  
 
Synthesis of TrS-COOH (3.2) 
As reported in the literature, under argon atmosphere, 3-mercaptopropionic acid 
(1.50 mL, 17.2 mmol) was added to a solution of tritylchloride (3.6 g, 12.8 
mmol) in anhydrous CH2Cl2 (500 mL). The reaction was left overnight at room temperature 
and then concentrated to give a yellow solid. The crude yellow solid was washed with a cold 
mixture of hexanes/Et2O (1:1) to give a white solid that was collected by vacuum filtration. 
The resulting white solid was then dissolved in a minimum amount of CH3OH with boiling, 
cooled to room temperature, added H2O (30 mL) then cooled on ice.  The recrystallized white 
solid was collected by vacuum filtration to give the purified acid compound (3.17 g, 84% 
yield). 1H NMR (600 MHz, CDCl3): " 7.42 (d, J = 6 Hz, 6H), 7.29 (t, J = 6Hz, 6H), 7.22 (t, J 
= 6 Hz, 3H), 2.47 (t, J = 6 Hz, 2H), 2.25 (t, J = 6 Hz, 2H). 13C{1H] NMR (75 MHz, CDCl3): " 
174.1, 144.5, 129.3, 127.7, 126.5, 66.6, 33.1, 26.7. IR (cm-1): 3057, 3035, 2928, 1709, 1595, 
1489, 1444, 1249, 1083, 1034, 934, 743, 700, 676, 622, 507, 488, 465. ESI-HRMS: Calculated 
for C22H20O2S+ [M+Na]+: 371.1076, found 371.1087. 
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Synthesis of TrS-NHS (3.3) 
As reported in the literature, to a solution of N-hydroxysuccinimide (0.41 g, 
3.56 mmol), DCC (0.76 g, 3.68 mmol) and a catalytic amount of DMAP 
(13.2 mg, 0.11 mmol) in anhydrous THF (30 mL) was added Ph3CS-(CH2)2-
COOH (1.07 g, 3.07 mmol) at 0˚C under argon atmosphere. The reaction was cooled for one 
hour and then left at room temperature overnight. The solution was filtered to remove the 
dicyclohexylurea and concentrated under vacuum. The crude reaction mixture was purified by 
silica gel column chromatography using CH2Cl2 to give the purified ester compound as a white 
solid (0.98 g, 72% yield). 1H NMR (600 MHz, CDCl3): " 7.44 (d, J = 6 Hz, 6H), 7.31 (t, J = 
6Hz, 6H), 7.23 (t, J = 6 Hz, 3H), 2.81 (s, 4H), 2.56 (t, J = 6 Hz, 2H), 2.41 (t, J = 6 Hz, 2H). 
13C{1H} NMR (75 MHz, CDCl3): " 168.8, 167.0, 144.3, 129.5, 128.0, 126.8, 67.1, 30.5, 26.1, 
25.5. IR (cm-1): 3080, 3024, 2937, 1809, 1775, 1745, 1485, 1441, 1356, 1207, 1153, 1088, 
1065, 991, 907, 845, 809, 743, 703, 648, 625, 506. ESI-HRMS: Calculated for C26H23NO4S+ 
[M+Na]+: 468.1240, found 468.1230. 
 
Synthesis of TsO-EG4-OH (3.5) 
To a solution of tetraethylene glycol (100 mL, 0.51 mol) in THF 
(150 mL) was added NaOH (3.4 g dissolved in 10 mL H2O) and the reaction mixture was 
stirred vigorously for 15 min. At 0˚C, p-toluenesulfonyl chloride (10.5 g, 0.061 mol) was then 
slowly added to give a yellow solution. The reaction was left overnight at room temperature 
then H2O (150 mL) was added. The reaction mixture was then extracted with CH2Cl2 (3 x 80 
mL), dried over Na2SO4, filtered and concentrated under vacuum to give the mono-tosylated 
product as a yellow oil (16.57 g, 78% yield). 1H NMR (600 MHz, CDCl3): " 7.81 (d, J = 12 
Hz, 2H), 7.35 (d, J = 12 Hz, 2H), 4.17 (t, J = 6 Hz, 2H), 3.73-3.60 (m, 14H), 2.45 (s, 3H). 
13C{1H} NMR (75 MHz, CDCl3): " 144.7, 132.8, 129.7, 127.8, 72.4, 70.6, 70.5, 70.3, 70.2, 
69.2, 68.6, 21.5. IR (cm-1): 3440, 2871, 1598, 1452, 1351, 1175, 1096, 1012, 918, 816, 774, 
662, 553. CI-HRMS: Calculated for C15H24O7S+ [M+1]+: 348.1243, found 348.1242.  
 
Synthesis of TsO-EG4-COOH (3.6) 
As reported in the literature, under argon atmosphere, to a 
solution of periodic acid (9.5 g, 42.7 mmol) dissolved in 
anhydrous CH3CN (250 mL) was added TsO-EG4-OH (6.6 g, 18.9 mmol). The reaction 
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mixture was cooled to 0˚C then a catalytic amount of PCC (83 mg, 0.4 mmol) was added. The 
reaction was left at room temperature for 3.5h to give a yellow-green solution. EtOAc (500 
mL) was added and the organic layer was separated and then successively washed with 1:1 
brine/H2O (3 x 500 mL), NaHSO3 (3 x 500mL) and brine (3 x 500 mL). The organic layer was 
then dried over Na2SO4, filtered and concentrated under vacuum to give the desired acid as a 
light yellow oil (6.3 g, 92% yield). No further purification was performed.  
 
Synthesis of TsO-EG4-COOMe (3.7) 
To a solution of TsO-EG4-COOH dissolved in CH3OH (400 
mL) was added H2SO4 (40 mL). The solution was then heated 
at reflux for 2 hours. The solution was concentrated under vacuum then re-dissolved in EtOAc 
(200 mL) and neutralized by the addition of a solution of 10% NaHCO3 (400 mL). The aqueous 
layer was extracted with EtOAc (3 x 200 mL). The combined organic layers were dried over 
Na2SO4, filtered and concentrated under vacuum. The solution was purified by silica gel 
column chromatography using EtOAc to give the desired methyl ester as a light yellow oil (3.7 
g, 56% yield). 1H NMR (600 MHz, CDCl3): " 7.81 (d, J = 12 Hz, 2H), 7.35 (d, J = 12 Hz, 2H), 
4,17 (s, 2H), 3.76-3.61 (m, 15H), 2.46 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): " 170.9, 
144.8, 133.0, 129.8, 128.0, 70.9, 70.7, 70.6, 70.5, 69.2, 68.7, 68.6, 51.2, 21.6.  ESI-HRMS: 
Calculated for C16H24O8S+ [M+Na]+: 399.1084, found 399.1086. 
 
Synthesis of N3-EG4-COOMe (3.8) 
To a solution of TsO-EG4-COOMe (1.06 g, 2.82 mmol) 
dissolved in CH3CN (20 mL) was added NaN3 (0.36 g, 5.54 
mmol) and heated at reflux for 48 h. A white precipitate formed. The reaction mixture was 
filtered and concentrated under vacuum. The crude mixture was purified by silica gel column 
chromatography using EtOAc to give the desired azido compound as a light yellow oil (553 
mg, 80% yield). 1H NMR (600 MHz, CDCl3): " 4.18 (s, 2H), 3.78-3.67 (m, 13H), 3.39 (t, J = 
12 Hz, 2H). 13C{1H} NMR (75 MHz, CDCl3): " 170.7, 70.7, 70.5, 70.45, 70.44, 69.8, 68.4, 
51.6, 50.5. IR (cm-1): 2069, 2098, 1753, 1439, 1348, 1283, 1210, 1116, 937, 852, 706. CI-
HRMS: Calculated for C9H18N3O5+ [M+1]+: 248.1241, found 248.1246. 
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Synthesis of MeO-EG3-OTs (3.10) 
 As reported in the literature, to a solution of triethylene glycol 
monomethyl ether (10 mL, 62 mmol) in CH2Cl2 (400 mL) was added triethylamine (20 mL) 
and DMAP (1.8 g, 15 mmol). At 0˚C, p-toluenesulfonyl chloride (14.5 g, 76 mmol) was then 
slowly added to give a yellow solution. The reaction was for 4 hours at room temperature and 
then concentrated under vacuum. The crude mixture was redissolved in acetone to give a white 
precipitate, filtered and concentrated under vacuum. The solution was then purified by silica 
gel column chromatography using EtOAc to give the tosylated product as a yellow oil (11.8 g, 
60% yield). 13C{1H} NMR (75 MHz, CDCl3): " 175.1, 144.7, 133.0, 129.8, 127.9, 71.9, 70.7, 
70.5, 69.3, 68.6, 59.0, 21.6. 13C {1H} NMR (75 MHz, CDCl3): " 144.7, 132.9, 129.8, 127.9, 
71.8, 70.7, 70.51, 70.49, 69.2, 68.6, 59.0, 21.6. IR (cm-1): 2876, 1598, 1452, 1353, 1175, 1096, 
1017, 918, 816, 774, 663, 554. EI-HRMS: Calculated for C14H22O6S+ [M]+: 318.1137, found 
318.1143. 
 
Synthesis of MeO-EG3-N3 (3.11) 
As reported in the literature, to a solution of NaN3 (1.70 g, 26.15 
mmol) dissolved in DMF (100 mL) was added MeO-EG3-OTs (4.09 g, 12.85 mmol). The 
reaction was heated at reflux for 48 hours. H2O (100 mL) was then added to the reaction 
mixture and performed an extraction with EtOAc (100 mL). The organic layer was washed 
with H2O (3 x 30 mL). The combined organic layers were dried over Na2SO4, filtered and 
concentrated under vacuum. The solution was purified by silica gel column chromatography 
using 1:1 EtOAc/hexanes to give the desired azido compound as a light yellow oil (1.22 g, 
50% yield). 1H NMR (600 MHz, CDCl3): " 3.69-3.65 (m, 8H), 3.57-3.55 (m, 2H), 3.41-3.39 
(m, 5H). 13C{1H} NMR (75 MHz, CDCl3): " 71.9, 70.7, 70.6, 70.5, 70.0, 59.0, 50.6. IR (cm-
1): 2872, 2097, 1452, 1347, 1285, 1199, 1106, 1029, 934, 851, 646, 557. CI-HRMS: Calculated 
for C9H18N3O5+ [M+1]+: 190.1192, found 190.1189. 
 
Synthesis of MeO-EG3-NH2 (3.12) 
Under hydrogen atmosphere, Pd/C (0.060 mg) was suspended in 
MeOH (5 mL) purged with hydrogen. Then MeO-EG3-N3 (0.011 g, 0.58 mmol) dissolved in 
MeOH (5 mL) was added to the reaction flask. The reaction was left for 3 h. Then the solution 
was filtered with celite to give the final amino compound (0.09 mg, 95% yield). 1H NMR (600 
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MHz, CDCl3): " 3.67-3.53 (m, 10H), 3.39 (s, 3H), 2.91-2.89 (m, 2H), 2.16 (bs, 2H). 13C{1H} 
NMR (75 MHz, CDCl3): " 71.3, 71.0, 70.0, 69.9, 69.9, 58.4, 50.8. CI-HRMS: Calculated for 
C9H18NO3+ [M+1]+: 164.1287, found 164.1283. 
 
Synthesis of TrS-EG3-OMe (3.13) 
To a solution of TrS-NHS (27.5 mg, 0.17 mmol) in anhydrous 
CH2Cl2 (7 mL) was added MeO-EG3-NH2 (50.0 mg, 0.11 
mmol) and a few drops of Et3N. The reaction was left at room temperature for 18h then 
concentrated under vacuum. The crude reaction mixture was purified by silica gel column 
chromatography using EtOAc to give the purified compound as a light yellow oil (48.7 mg, 
89% yield). 1H NMR (600 MHz, CDCl3): " 7.42 (d, J = 6Hz, 6H), 7.28 (t, J = 6Hz, 6H), 7.21 
(t, J = 6Hz, 3H), 5.99 (bs, 1H), 3.62-3.60 (m, 6H), 3.55-3.54 (m, 2H), 3.52-3.51 (m, 2H), 3.40-
3.37 (m, 5H), 2.50 (t, J = 6Hz, 2H), 2.05 (t, J = 6Hz, 2H). 13C{1H} NMR (75 MHz, CDCl3): " 
170.9, 144.7, 129.5, 127.9, 126.6, 71.9, 70.5, 70.4, 70.1, 69.7, 59.0, 39.2, 35.4, 27.7.  
 
Synthesis of HS-EG3-OMe (3.14) 
To a solution of TrS-EG3-OMe (110 mg, 0.22 mmol) dissolved 
in anhydrous CH2Cl2 (5 mL) was added TIPS (0.2 mL) then 
TFA (0.5 mL). The reaction was left at room temperature for 3 hours and then concentrated 
under vacuum. The crude reaction mixture was purified by silica gel column chromatography 
using 5:1 CH2Cl2/i-PrOH to give the final product as a light yellow oil. 1H NMR (600 MHz, 
CDCl3): " 6.45 (bs, 1H), 3.66-3.64 (m, 6H), 3.59-3.58 (m, 4H), 3.50-3.48 (m, 2H), 3.40-3.39 
(m, 3H), 2.84-2.80 (m, 2H), 2.54-2.50 (m, 2H), 1.63 (t, 1H). 13C{1H} NMR (75 MHz, CDCl3): 
" 172.6, 71.9, 70.4, 70.3, 70.2, 69.8, 59.0, 40.3, 39.3, 20.5. EI-HRMS: Calculated for 
C37H50N2O8S+ [M-H]+: 250.1119, found 250.1104. 
 
Synthesis of TrS-EG4-COOMe (3.15) 
Under hydrogen atmosphere, to a suspension of Pd/C 
(60 mg) in 2:3 CH2Cl2/MeOH (15 mL) purged with 
hydrogen was added TrS-NHS (0.25 g, 0.56 mmol). Then N3-EG4-COOMe (0.10 g, 0.40 
mmol) dissolved in MeOH (5 mL) was added to the reaction flask. The reaction was stirred at 
room temperature for 3 h under hydrogen atmosphere. A small amount of Et3N was then added 
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and the reaction was left to stir overnight under an argon atmosphere. The solution was then 
filtered with celite and concentrated under vacuum. The solution was purified by silica gel 
column chromatography using EtOAc to give the desired amide coupled compound (0.158 mg, 
72% yield). 1H NMR (600 MHz, CDCl3): " 7.38 (d, J = 12 Hz, 6H), 7.25 (t, J = 12 Hz, 6H), 
7.17 (t, J = 12 Hz, 3H), 5.93 (bs, 1H), 4.12 (s, 2H), 3.70-3.57 (m, 5H), 3.64-3.62 (m, 2H), 3.58-
3.54 (m, 4H), 3.49-3.46 (m, 2H), 3.37-3.33 (m, 2H), 2.46 (t, J = 12 Hz, 2H), 2.02 (t, J = 12 Hz, 
2H). 13C{1H} NMR (75 MHz, CDCl3): " 171.0, 170.8, 144.7, 129.5, 127.9, 126.6, 70.8, 70.5, 
70.4, 70.1, 69.8, 68.5, 66.7, 51.8, 39.2, 35.4, 27.7. IR (cm-1): 3314, 3056, 2870, 1753, 1651, 
1537, 1488, 1443, 1350, 1211, 1118, 1034, 853, 745, 701, 622. ESI-HRMS: Calculated for 
C31H37NO6S+ [M+Na]+: 574.2234, found 574.2234. 
 
Synthesis of TrS-EG4-COOH (3.16) 
To a solution of TrS-EG4-COOMe (439.6 mg, 0.80 
mmol) dissolved in H2O (30 mL) was added K2CO3 (1.0 
g). The reaction was heated at reflux for two hours. The reaction mixture was then cooled to 
room temperature and acidified to pH = 1 using 1M HCl. The acidified solution was then 
extracted using CH2Cl2 (4 x 20 mL). The combined organic layers were dried over Na2SO4, 
filtered and concentrated under vacuum to give the desired acid compound as a clear and 
colorless oil (0.40 g, 93 % yield). 1H NMR (600 MHz, CDCl3): " 7.42 (d, J = 12 Hz, 6H), 7.29 
(t, J = 12 Hz, 6H), 7.21 (t, J = 12 Hz, 3H), 6.26 (bs, 1H), 4.16 (s, 2H), 3.78-3.75 (m, 2H), 3.69-
3.66 (m, 4H), 3.62-3.60 (m, 2H), 3.54-3.50 (m, 2H), 3.44-3.40 (m, 2H), 2.49 (t, J = 12 Hz, 2H), 
2.18 (t, J = 12 Hz, 2H). 13C{1H} NMR (75 MHz, CDCl3): " 171.44, 171.39, 144.7, 129.6, 
127.9, 126.6, 71.6, 70.6, 70, 69.8, 69.1, 66.7, 39.2, 35.2, 27.8. ESI-HRMS: Calculated for 
C30H35NO6S+ [M+Na]+: 560.2077, found 560.2073. 
 
Synthesis of TrS-EG4-EG3-OMe (3.17) 
Under argon atmosphere, to a solution 
of TrS-EG4-COOH (338 mg, 0.63 
mmol) and HBTU (334 mg, 0.88 mmol) dissolved in anhydrous CH3CN (15 mL) was added 
MeO-EG3-NH2 (120 mg, 0.74 mmol) and DIPEA (0.3 mL, 1.7 mmol). The reaction was left 
overnight and then concentrated under vacuum. The crude reaction mixture was purified by 
silica gel column chromatography using 5% MeOH in CH2Cl2 to give the desired product (209 
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mg, 47% yield). 1H NMR (600 MHz, CDCl3): " 7.41 (d, J = 6 Hz, 6H), 7.28 (t, J = 6 Hz, 6H), 
7.21 (t, J = 6 Hz, 3H), 7.16 (bs, 1H), 6.30 (bs, 1H), 4.04 (s, 2H), 3.68-3.67 (m, 2H), 3.65-3.49 
(m, 20H), 3.40-3.37 (m, 5H), 2.49 (t, J = 12 Hz, 2H), 2.09 (t, J = 12 Hz, 2H). 13C{1H} NMR 
(75 MHz, CDCl3): " 171.1, 170.1, 144.7, 129.6, 127.9, 126.6, 71.9, 70.6, 70.49, 70.45, 70.43, 
70.36, 70.2, 70.1, 69.9, 69.8, 66.6, 59.0, 39.2, 38.6, 35.2, 27.7. IR (cm-1): 3422, 3317, 3058, 
2971, 1658, 1536, 1489, 1444, 1349, 1250, 1107, 1034, 744, 702. ESI-HRMS: Calculated for 
C37H50N2O8S+ [M+Na]+: 705.3180, found 705.3187. 
 
Synthesis of HS-EG4-EG3-OMe (3.18) 
To a solution of TrS-EG4-EG3-OMe 
(124.9 mg, 0.18 mmol) dissolved in 
anhydrous CH2Cl2 (5 mL) was added TIPS (0.2 mL) then TFA (0.5 mL). The reaction was left 
at room temperature for 2 hours and then concentrated under vacuum. The crude reaction 
mixture was purified by silica gel column chromatography using 4:1 CH2Cl2/i-PrOH to give 
the final ligand as a clear and colorless oil (62 mg, 78% yield). 1H NMR (600 MHz, CDCl3): 
7.21 (bs, 1H), 6.72 (bs, 1H), 4.08 (s, 2H), 3.71-3.69 (m, 2H), 3.67-3.62 (m, 12H), 3.60-3.53 
(m, 6H), 3.52-3.45 (m, 4H), 3.37 (s, 3H), 2.80 (q, J = 12 Hz, 2H), 2.51 (t, J = 12 Hz, 2H), 1.62 
(t, J = 12 Hz, 1H). 13C{1H} NMR (75 MHz, CDCl3): 171.0, 170.4, 71.8, 70.7, 70.6, 70.44, 
70.43, 70.34, 70.2, 70.1, 69.9, 69.7, 59.0, 40.1, 39.3, 38.6, 20.5. IR (cm-1): 3515, 3313, 3084, 
2872, 2550, 1651, 1543, 1452, 1349, 1286, 1251, 1200, 1101, 940, 850, 576. EI-HRMS: 
Calculated for C18H3N2O8S+ [M+H]+: 441.2265, found 441.2284. 
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CHAPTER(4(
4.1$Conclusion$
 
The Workentin AuNP toolbox was developed in order to allow for tuning and 
application of the unique size-dependent physical, chemical and biological properties of 
AuNPs by designing functional templates with click and bioorthogonal functional groups. For 
example, our group was the first to introduce strained alkyne functionality onto AuNPs and 
demonstrate its interfacial SPAAC reactivity.[1] We then expanded the scope of strained alkyne 
chemistry by developing a protection-deprotection strategy via the formation of a 
dicobalthexacarbonyl complex.[2] As part of my undergraduate thesis project, we reported the 
functionalization of a CO2(CO)6-protected bicyclononyne complex that could be subsequently 
deprotected to regenerate the strained alkyne functionality. Although this was an excellent 
protection-deprotection strategy for small molecule chemistry, our group transitioned towards 
photoreactive cyclopropenone-based strategies for the modification of nanomaterials as a 
result of the undesirable reactivity of alkyne-Co2(CO)6 complexes towards nucleophiles, 
including thiols. By preparing photoDIBO-AuNP precursors that upon irradiation by UV light 
could generate strained alkyne functionalized AuNPs, our group expanded the AuNP toolbox 
by the addition of photochemical spatial and temporal control of reactivity.[3]  
In Chapter 2, I described my addition to the AuNP click and bioorthogonal toolbox 
through a light activated and photo-reversible click and bioorthogonal functional group that 
will allow for unprecedented temporal and spatial control of photo-reactivity. The introduction 
of oNQM functionality was achieved via place exchange reaction onto methoxy-terminated 
AuNPs to provide an organic and water-soluble template. This required the synthesis of a 
complex thiol-modified NQMP ligand. The challenging synthetic protocol and 
characterization of all synthetic intermediates by 1H NMR, 13C NMR and IR spectroscopy as 
well as MS was reported in Chapter 2. The final ligand was synthesized in good yield through 
a selective deprotection strategy using acid/base sensitive protecting groups. The NQMP 
functional group was then successfully introduced onto a AuNP surface via place exchange 
with an approximate 20% loading that can be controlled by altering the reaction conditions 
such as a ratio of thiol to gold and reaction time. The novel template was characterized by 1H 
NMR spectroscopy, IR spectroscopy, TGA and TEM. The spectral data confirmed the presence 
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the NQMP ligand and TEM images revealed no significant change in regards to the size or 
shape of the gold core following place exchange when compared to the precursor AuNP. The 
photochemical properties were also investigated by UV-Vis spectroscopy revealing absorption 
maxima at 260 nm and 342 nm suitable for activation to the corresponding oNQM 
functionality. Figure 4.1 describes the introduction of this novel click and bioorthogonal 
functional group into the Workentin AuNP toolbox.  
 
 
Figure 4.1: The Workentin AuNP toolbox reprinted with the addition of the NQMP-
functionalized AuNP template developed in this thesis.  
 
In Chapter 3, my aim was to develop a method to transfer the methods we have 
developed for the functionalization of small AuNPs onto larger AuNP systems in order to take 
advantage of the SPR. However, large AuNPs are much more difficult to stabilize than their 
small counterpart and subsequent functionalization is quite limited. In this chapter I described 
the synthesis of a novel ligand through a convergent approach by conjugating three different 
fragments through the formation of amide bonds. The design of this ligand included an amide 
bond pattern to provide additional stabilization as well as a repeating unit to increase the size 
of the ligand to account for larger AuNP core sizes. All three fragments were successfully 
synthesized in good yield so it is feasible to scale up the synthesis and generate large amounts 
of whatever ligand length is desired. In this chapter, the ligand was synthesized with one 
repeating unit and incorporated onto 20 nm AuNPs through a place exchange reaction with 
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citrate-stabilized AuNPs. Through UV-Vis spectroscopy, preliminary results indicated that the 
place exchange reaction was successful. No discoloration of the solution was observed and 
TEM images indicated that no aggregation occurred following place exchange.  
 
4.2$Future$Work$
$
Future developments with the novel NQMP-functionalized AuNP template developed 
in Chapter 2 will be to investigate the photochemical generation of oNQM and subsequent 
photochemical reactivity towards hetero-Diels-Alder cycloaddition and Michael Addition 
substrates. In particular, the resulting thioether linkage in the Michael Addition adduct between 
oNQM and a thiol may be photochemically cleaved to regenerate both starting materials for 
applications such as patterning and delivery systems.  
The work presented in Chapter 3 detailed the first steps towards the stabilization and 
functionalization of large AuNPs via click and bioorthogonal chemistry. Future developments 
include a phase transfer protocol into organic media to for characterization via 1H NMR 
spectroscopy. The synthetic strategy may then be modified to incorporate click and 
bioorthogonal functional groups from our AuNP toolbox and investigate the interfacial 
chemistry properties of this novel system. 
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2.A Characterization of HO-NQMP 
 
Figure 2.A1: 1H NMR spectrum of HO-NQMP in CD3OD. * denotes solvent signals. 
 
Figure 2.A2: 13C{1H} spectrum of HO-NQMP in CD3OD. * denotes solvent signal(s).  
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2.B Characterization of HO-NQMP-pt 
 
Figure 2.B1: 1H NMR spectrum of HO-NQMP-pt in CD3OD. * denotes solvent signal(s). 
 
Figure 2.B2: 13C{1H} spectrum of HO-NQMP-pt in CD3OD. * denotes solvent signal(s). 
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Figure 2.B3: IR absorption spectrum of HO-NQMP-pt. 
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2.C Characterization of TsO-EG4-OH 
 
Figure 2.C1: 1H NMR spectrum of TsO-EG4-OH in CDCl3. * denotes solvent signal(s). 
 
Figure 2.C2: 13C{1H} spectrum of TsO-EG4-OH in CDCl3. * denotes solvent signal(s). 
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Figure 2.C3: IR absorption spectrum of TsO-EG4-OH. 
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2.D Characterization of AcS-EG4-OH 
 
Figure 2.D1: 1H NMR spectrum AcS-EG4-OH in CDCl3. * denotes solvent signal(s). 
 
Figure 2.D2: 13C{1H} spectrum of AcS-EG4-OH in CDCl3. * denotes solvent signal(s). 
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Figure 2.D3: IR absorption spectrum of AcS-EG4-OH. 
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2.E Characterization of AcS-EG4-I 
 
Figure 2.E1: 1H NMR spectrum of AcS-EG4-I in CDCl3. * denotes solvent signal(s). 
 
Figure 2.E2: 13C{1H} spectrum of AcS-EG4-I. * denotes solvent signal(s). 
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Figure 2.E3: IR absorption spectrum of AcS-EG4-I. 
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2.F Characterization of AcS-EG4-NQMP-pt 
 
Figure 2.F1: 1H NMR spectrum of AcS-EG4-NQMP-pt in CDCl3. * denotes solvent 
signal(s). 
 
Figure 2.F2: 13C{1H} spectrum of AcS-EG4-NQMP-pt in CDCl3. * denotes solvent signal(s). 
!! !
88 
 
Figure 2.F3: IR absorption spectrum of AcS-EG4-NQMP-pt. 
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2.G Characterization of AcS-EG4-NQMP 
 
Figure 2.G1: 1H NMR spectrum of AcS-EG4-NQMP in CDCl3. * denotes solvent signal(s). 
 
Figure 2.G2: 13C{1H} spectrum of AcS-EG4-NQMP in CDCl3. * denotes solvent signal(s).  
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2.H Characterization of HS-EG4-NQMP 
 
Figure 2.H1: 1H NMR spectrum of HS-EG4-NQMP in CDCl3. * denotes solvent signal(s). 
 
Figure 2.H2: 13C{1H} spectrum of HS-EG4-NQMP in CDCl3. * denotes solvent signal(s). 
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Figure 2.H3: IR absorption spectrum of HS-EG4-NQMP. 
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2.I Characterization of HO-EG4-TrS 
 
Figure 2.I1: 1H NMR spectrum of HO-EG4-TrS in CDCl3. * denotes solvent signal(s). 
 
Figure 2.I2: 13C{1H} spectrum of HO-EG4-TrS in CDCl3. * denotes solvent signal(s). 
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Figure 2.I3: IR absorption spectrum of HO-EG4-TrS. 
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2.J Characterization of I-EG4-TrS 
 
Figure 2.J1: 1H NMR spectrum of I-EG4-TrS in CDCl3. * denotes solvent signal(s). 
 
Figure 2.J2: 13C{1H} spectrum of I-EG4-TrS in CDCl3. * denotes solvent signal(s). 
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Figure 2.J3: IR absorption spectrum of I-EG4-TrS. 
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2.K Characterization of TrS-EG4-NQMP-pt 
 
Figure 2.K1: 1H NMR spectrum of TrS-EG4-NQMP-pt in CDCl3. * denotes solvent 
signal(s). 
 
Figure 2.K2: 13C{1H} spectrum of TrS-EG4-NQMP-pt in CDCl3. * denotes solvent signal(s). 
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Figure 2.K3: IR absorption spectrum of TrS-EG4-NQMP-pt. 
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2.L Characterization of TrS-EG4-NQMP 
 
Figure 2.L1: 1H NMR spectrum of TrS-EG4-NQMP in CDCl3. * denotes solvent signal(s). 
 
Figure 2.L2: 13C{1H} spectrum of TrS-EG4-NQMP in CDCl3. * denotes solvent signal(s).  
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3.A Characterization of Ph3CS-(CH2)2-COOH 
 
Figure 3.A1: 1H NMR spectrum of Ph3CS-(CH2)2-COOH in CDCl3. * denotes solvent 
signal(s). 
 
Figure 3.A2: 13C{1H} spectrum of Ph3CS-(CH2)2-COOH in CDCl3. * denotes solvent 
signal(s).  
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Figure 3.A3: IR absorption spectrum of Ph3CS-(CH2)2-COOH. 
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3.B Characterization of Ph3CS-(CH2)2-NHS 
 
Figure 3.B1: 1H NMR spectrum of Ph3CS-(CH2)2-NHS in CDCl3. * denotes solvent 
signal(s). 
 
Figure 3.B2: 13C{1H} spectrum of Ph3CS-(CH2)2-NHS in CDCl3. * denotes solvent 
signal(s). 
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Figure 3.B3: IR absorption spectrum of Ph3CS-(CH2)2-NHS. 
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3.C Characterization of TsO-EG4-OH 
 
Figure 3.C1: 1H NMR spectrum of TsO-EG4-OH in CDCl3. * denotes solvent signal(s). 
 
Figure 3.C2: 13C{1H} spectrum of TsO-EG4-OH in CDCl3. * denotes solvent signal(s). 
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Figure 3.C3: IR absorption spectrum of TsO-EG4-OH. 
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3.D Characterization of TsO-EG4-COOMe 
!  
Figure 3.D1: 1H NMR spectrum of TsO-EG4-COOMe in CDCl3. * denotes solvent signal(s). 
 
Figure 3.D2: 13C{1H} spectrum of TsO-EG4-COOMe in CDCl3. * denotes solvent signal(s). 
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3.E Characterization of N3-EG4-COOMe 
 
Figure 3.E1: 1H NMR spectrum of N3-EG4-COOMe in CDCl3. * denotes solvent signal(s). 
 
Figure 3.E2: 13C{1H} spectrum of N3-EG4-COOMe in CDCl3. * denotes solvent signal(s). 
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Figure 3.E3: IR absorption spectrum of N3-EG4-COOMe. 
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3.F Characterization of MeO-EG3-OTs 
 
Figure 3.F1: 1H NMR spectrum of MeO-EG3-OTs in CDCl3. * denotes solvent signal(s). 
 
Figure 3.F2: 13C {1H} spectrum of MeO-EG3-OTs in CDCl3. * denotes solvent signal(s). 
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Figure 3.F3: IR absorption spectrum of MeO-EG3-OTs. 
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3.G Characterization of MeO-EG3-N3 
 
Figure 3.G1: 1H NMR spectrum of MeO-EG3-N3 in CDCl3. * denotes solvent signal(s). 
 
Figure 3.G2: 13C{1H} spectrum of MeO-EG3-N3 in CDCl3. * denotes solvent signal(s). 
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Figure 3.G3: IR absorption spectrum of MeO-EG3-N3. 
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3.H Characterization of MeO-EG3-NH2 
 
Figure 3.H1: 1H NMR spectrum of MeO-EG3-NH2 in CDCl3. * denotes solvent signal(s). 
 
Figure 3.H2: 13C{1H} spectrum of MeO-EG3-NH2 in CDCl3. * denotes solvent signal(s). 
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3.I Characterization of Ph3CS-EG3-OMe 
 
Figure 3.I1: 1H NMR spectrum of Ph3CS-EG3-OMe in CDCl3. * denotes solvent signal(s). 
 
Figure 3.I2: 13C{1H} spectrum of Ph3CS-EG3-OMe in CDCl3. * denotes solvent signal(s).  
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3.J Characterization of HS-EG3-OMe 
 
Figure 3.J1: 1H NMR spectrum of HS-EG3-OMe in CDCl3. * denotes solvent signal(s). 
 
Figure 3.J2: 13C{1H} spectrum of HS-EG3-OMe in CDCl3. * denotes solvent signal(s).  
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3.K Characterization of Ph3CS-EG4-COOMe 
 
Figure 3.K1: 1H NMR spectrum of Ph3CS-EG4-COOMe in CDCl3. * denotes solvent 
signal(s). 
 
Figure 3.K2: 13C{1H} spectrum of Ph3CS-EG4-COOMe in CDCl3. * denotes solvent 
signal(s). 
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Figure 3.J3: IR absorption spectrum of Ph3CS-EG4-COOMe. 
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3.L Characterization of Ph3CS-EG4-COOH 
 
Figure 3.L1: 1H NMR spectrum of Ph3CS-EG4-COOH in CDCl3. * denotes solvent 
signal(s). 
 
Figure 3.L2: 13C{1H} spectrum of Ph3CS-EG4-COOH in CDCl3. * denotes solvent signal(s). 
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3.M Characterization of Ph3CS-EG4-EG3-OMe 
!
Figure 3.M1: 1H NMR spectrum of Ph3CS-EG4-EG3-OMe in CDCl3. * denotes solvent 
signal(s). 
 
Figure 3.M2: 13C{1H} spectrum of Ph3CS-EG4-EG3-OMe in CDCl3. * denotes solvent 
signal(s). 
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Figure 3.M3: IR absorption spectrum of Ph3CS-EG4-EG3-OMe. 
 
  
!! !
121 
3.N Characterization of HS-EG4-EG3-OMe 
!
Figure 3.N1: 1H NMR spectrum of HS-EG4-EG3-OMe in CDCl3. * denotes solvent signal(s). 
 
Figure 3.N2: 13C{1H} spectrum of HS-EG4-EG3-OMe in CDCl3. * denotes solvent signal(s).  
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Figure 3.M3: IR absorption spectrum of HS-EG4-EG3-OMe. 
!
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